Skip to main content
Frontiers in Neuroscience logoLink to Frontiers in Neuroscience
. 2023 Jun 30;17:1172779. doi: 10.3389/fnins.2023.1172779

Structural neuroimaging phenotypes and associated molecular and genomic underpinnings in autism: a review

Charlotte M Pretzsch 1,*, Christine Ecker 2
PMCID: PMC10347684  PMID: 37457001

Abstract

Autism has been associated with differences in the developmental trajectories of multiple neuroanatomical features, including cortical thickness, surface area, cortical volume, measures of gyrification, and the gray-white matter tissue contrast. These neuroimaging features have been proposed as intermediate phenotypes on the gradient from genomic variation to behavioral symptoms. Hence, examining what these proxy markers represent, i.e., disentangling their associated molecular and genomic underpinnings, could provide crucial insights into the etiology and pathophysiology of autism. In line with this, an increasing number of studies are exploring the association between neuroanatomical, cellular/molecular, and (epi)genetic variation in autism, both indirectly and directly in vivo and across age. In this review, we aim to summarize the existing literature in autism (and neurotypicals) to chart a putative pathway from (i) imaging-derived neuroanatomical cortical phenotypes to (ii) underlying (neuropathological) biological processes, and (iii) associated genomic variation.

Keywords: autism, autism spectrum disorder, neuroanatomy, cortical thickness, surface area, cortical volume, gyrification, grey-white matter tissue contrast

1. Introduction

Autism spectrum disorder (ASD; henceforth referred to as autism) is a lifelong, complex, multifactorial, neuropsychiatric condition reported to occur in 1 out of 54 individuals (Knopf, 2020). Core features include social communication difficulties and restricted and repetitive patterns of interests and behaviors (American Psychiatric Association, 2013). These symptoms are accompanied by multifaceted differences in brain structure. For instance, structural magnetic resonance imaging (sMRI) studies have identified differences in (the developmental trajectories of) multiple neuroanatomical cortical features. Among these are the commonly implicated cortical thickness, surface area, cortical volume, measures of gyrification, and the grey-white matter tissue contrast (GWC) (Pretzsch and Ecker, 2022). Combined, these neuroimaging features have been proposed as intermediate phenotypes on the gradient from genomic variation to behavioral symptoms (Carter et al., 2017). Therefore, examining what these cortical proxy markers represent, i.e., disentangling their associated molecular and genomic underpinnings, could provide crucial insights into the etiology and pathophysiology of autism.

Previous studies suggest that inter-individual neuroanatomical variability at the macroscopic level may be influenced by microscopic variability. For example, postmortem studies have linked neuroanatomical differences to minicolumnar pathology, abnormal neuronal numbers and sizes etc [reviewed e.g., in Fetit et al., 2021]. This microscopic variability in turn is thought to result from a complex set of cellular/molecular processes rooted in genetic, epigenetic, and environmental features. In line with this, genetic studies in autism to date have implicated more than 1,000 genetic variants in the etiology of autism (O’Roak et al., 2012). Notably, the relationships between neuroanatomical variability and underlying neurobiological mechanisms and genomic features are complex and subject to significant heterogeneity. Nonetheless, an increasing number of studies are exploring these associations both indirectly and directly in vivo, across age, and for different neuroanatomical features.

Combined, this research has given rise to a wealth of publications. However, to our knowledge, no study or review article has yet attempted to integrate the information provided by these studies on typical and atypical neurodevelopment to chart a putative pathway from (1) commonly examined neuroanatomical imaging cortical phenotypes to (2) molecular mechanisms and (3) associated genomic variation. Hence, this is the aim of the present review. Note that here we focus on research in humans [reviews in mice: (Collins et al., 2019; Wang et al., 2020); reviews in zebrafish: (Anand and Mondal, 2020; Jenett, 2020)]. Also, we would like to highlight that this is not a review of imaging genetics studies per se, but a review of studies examining the biological associates of imaging markers (which include imaging genetics studies). Further, while there is a growing body of literature addressing the cerebellum in neurotypical and atypical individuals, the present review focuses on the cerebral cortex; for additional information concerning the cerebellum, we refer the reader to e.g (Fatemi et al., 2012; Hampson and Blatt, 2015; De Zeeuw et al., 2021). Finally, we recognize the crucial role of biological sex differences in genotypes, phenotypes (including neuroanatomy), and the genetic regulation of phenotypes, in both the neurotypical and autistic brain. For example, we recently reported an overlap between those neuroanatomical features characteristic of neurotypical males (vs. females) with those of autistic individuals (Floris et al., 2023). In autistic females, this male-shifted neuroanatomy was associated with gene expression patterns of midgestational cell-types (Floris et al., 2023). Taken together, these findings illustrate the complexity of sex differences in neuroimaging phenotypes and associated molecular mechanisms and genomic variation in the autistic and neurotypical brain. However, a discussion of these sex differences is beyond the scope of this review; hence, we refer the reader to previous work on this topic (e.g., Lai et al., 2015; Chen and Van Horn, 2017; Cauvet et al., 2019).

Hence, in this review, we will first outline different analytical techniques applied to sMRI data to derive commonly studied neuroanatomical features, including cortical thickness, surface area, cortical volume, cortical folding/gyrification, and the GWC. We will briefly discuss each feature and its development across age in neurotypicals and in autism. Second, we will introduce methods commonly used to examine the biological processes thought to contribute to neuroanatomy. We will provide a brief overview over shared and distinct developmental pathways between features and detail the potential microscopic underpinnings of each feature in neurotypicals and in autistic individuals. Third, we will summarize efforts to examine the genomic associates of these microscopic processes and macroscopic features. We will provide a brief overview over commonly used genomic analytic approaches. We will then outline the genomic features related to (atypical) cortical development and neuroanatomy in general, and each individual cortical feature, in neurotypicals and in autism. Fourth, we will discuss current and future research trends, including those based on existing limitations and the potential of large-scale collaborations. Fifth, we will conclude our review with a brief summary.

2. Neuroimaging features

The current gold standard for investigating neuroanatomy in vivo is sMRI, which includes T1-weighted imaging (high-level structural detail) and diffusion tensor imaging (DTI; captures white matter organization) (Schumann and Nordahl, 2011). This review will focus on T1-weighted imaging; for additional information concerning DTI, we refer the reader to e.g (Ranzenberger and Snyder, 2023). Similarly, a discussion of alternative neuroimaging modalities, including methods used to assess brain function (e.g., functional MRI) and brain biochemistry (e.g., magnetic resonance spectroscopy) is beyond the scope of this review, which centers on structural neuroimaging. Broadly, sMRI leverages the magnetic properties of different tissue types (e.g., gray and white matter) to produce high-resolution images of the brain. Traditional sMRI studies have explored neuroanatomy (based on cortical or regional brain volume) using time- and labor-intensive manual segmentation approaches, such as hand-tracing of individual pre-defined regions (e.g., Allen et al., 2002). To overcome these challenges, increasing efforts have been directed toward developing automated segmentation methods, including e.g., deep-learning approaches [reviewed in Fawzi et al. (2021)]. Also, advances in spatially unbiased computational techniques, e.g., voxel-based morphometry (VBM), have enabled the simultaneous volumetric examination of multiple (sub)cortical structures based on local concentrations of gray matter (Wright et al., 1995). Currently used techniques, such as surface-based morphometry (SBM) (MacDonald et al., 2000), now allow us to further disentangle the complex morphometric constituents underpinning cortical volume (i.e., cortical thickness and surface area); and to explore other features of neuroanatomy, including measures of curvature and the GWC (Pretzsch et al., 2019; Pretzsch and Ecker, 2022). In the following, we will briefly describe (1) how each of these morphometric measures is identified, (2) the (neuro)typical trajectory of different features, and (3) how−and where−individual features (and their developmental trajectory) differ in autism. Please note that, while our review focuses on a selection of commonly studied features, research on additional features is rapidly expanding. For instance, a recent study identified more extra-axial cerebrospinal fluid in autistic compared to neurotypical children, which may represent a potential early stratification biomarker (Shen et al., 2018).

2.1. Cortical thickness

Cortical thickness is commonly defined as the closest distance from the gray matter/white matter boundary (inner gray matter surface) to the gray matter/cerebrospinal fluid (CSF) boundary (outer gray matter surface) (Fischl et al., 1999). In neurotypicals, cortical thickness is thought to increase and peak early in life, followed by a rapid decrease during childhood and adolescence, and a decelerated decrease from adulthood onward (Huttenlocher, 1979; Fjell et al., 2015). In autism, large-scale studies have reported increased cortical thickness in frontal, temporal, parietal, and occipital regions from childhood onward, with differences diminishing during adulthood (Khundrakpam et al., 2017; Bedford et al., 2020). Also, autism has been associated with an accelerated thinning of the cortical mantle during adolescence and adulthood, particularly in the frontal, parietal, and occipital lobe (less in the temporal lobe) (Zielinski et al., 2014; Wallace et al., 2015). Combined, these studies point to region-dependent differences in cortical thickness, not only cross-sectionally, but also in terms of the developmental trajectory of cortical thickness in autism. Figures 1, 2A.

FIGURE 1.

FIGURE 1

Schematic of neuroimaging features mentioned in this review.

FIGURE 2.

FIGURE 2

Schematic of the development of the described neuroimaging features (A: cortical thickness, B: surface area, C: cortical volume, D: local gyrification index, and E: grey-white matter tissue contrast) in childhood, adolescence, and adults in neurotypicals (shown in blue) and autistic individuals (displayed in orange), where upward arrows indicate increases, horizontal arrows indicate stagnation/plateau, and downward arrows indicate decreases. Where research has been inconclusive/contradicting, multiple arrows are presented. Please note that this schematic is not comprehensive: different growth trajectories have been reported both within studies (e.g., for different brain regions) and between studies. For more information concerning neuroanatomical differences and their trajectories in autism, see e.g (Courchesne et al., 2007; Ecker et al., 2014, 2015; Zielinski et al., 2014; Lange et al., 2015; Mensen et al., 2016; Li et al., 2021).

2.2. Surface area

Surface area is typically quantified as the area of the cortex at a given point on the cortical surface (i.e., the sum of faces in the polygon mesh representation of the cortex at a particular vertex) (Winkler et al., 2012). In neurotypicals, surface area increases rapidly during early childhood (Lyall et al., 2015), with a peak in late childhood/adolescence (Raznahan et al., 2011b), and a decline throughout adulthood (Hogstrom et al., 2013). Previous studies show that surface area develops atypically in autism, with studies in young children reporting early overgrowth (resulting in an enlargement of the cortex) before the age of 2 years in temporal, frontal, parietal, and occipital regions (Hazlett et al., 2011). Following this, some studies have reported reduced surface area in childhood, followed by an atypically steep increase throughout adulthood (Ecker et al., 2014); while others reported reduced surface area in childhood followed by an atypically low decline, resulting in increased surface area in adulthood (Mensen et al., 2016). These discrepancies may be due to methodological considerations (e.g., investigated regions) and the large phenotypic heterogeneity that is characteristic of autism. Regardless, they point to regional differences in surface area in autism, which may further vary across age. Figures 1, 2B.

2.3. Cortical volume

Cortical volume is the product of cortical thickness and surface area. In neurotypicals, the development of cortical volume is thought to follow an inverted U-shape, peaking between ∼7–10 years of age (Raznahan et al., 2011b). Notably, cortical thickness and surface area contribute differently to cortical volume, although in neurotypical children, adolescents, and adults, (change in) cortical volume is thought to be driven predominantly by (change in) cortical thickness (Storsve et al., 2014; Ducharme et al., 2015). In autism, cortical volume is significantly increased during childhood, followed by a plateau during later childhood (∼8–9 years of age), and an accelerated decline from adolescence onward (Courchesne et al., 2011a). Moreover, the contributions of cortical thickness and surface area to cortical volume may differ in autism. More specifically, in autistic adults, spatial patterns of differences in cortical thickness and surface area were largely non-overlapping, i.e., the probability that any one point on the cortex displayed a difference in both cortical thickness and surface area was very low (Ecker et al., 2013). Given the distinct developmental trajectories of cortical thickness and surface area across age (Hazlett et al., 2011; Ecker et al., 2014; Wallace et al., 2015), it is possible that early (< 2 years) differences in cortical volume are driven by atypical surface area, while later (childhood/adolescence) differences are linked to atypical cortical thickness and/or surface area. Nonetheless, additional research is required to confirm this. Figures 1, 2C.

2.4. Gyrification

The local gyrification index (lGI) quantifies the ratio of inner sulcal folds compared to the outer smooth cortical surface (a larger lGI indicates greater cortical folding) (Schaer et al., 2012). In neurotypicals, studies examining the developmental trajectory of local gyrification have reported inconsistent results, with some studies showing a rapid increase during fetal development (White et al., 2010), an increase/stagnation/decrease in childhood (White et al., 2010; Libero et al., 2019), and a decrease in adolescence and adulthood (Klein et al., 2014). In autism, a longitudinal study in children reported lower lGI in the fusiform gyrus at 3 years of age (Libero et al., 2019). Moreover, unlike neurotypicals who displayed a stable/decreasing lGI, autistic children showed an increase in lGI in frontal, temporal, and parietal regions; and a stable lGI in the occipital lobe between the ages of 3 and 5 years of age (Libero et al., 2019). Further, studies in autistic adolescents have reported increased lGI in frontal, temporal, and parietal regions; as well as an accelerated decline in lGI in frontal, precentral, and occipital regions (Kohli et al., 2019a). Last, studies have reported widespread reductions in lGI in autistic adults (Kohli et al., 2019b). Taken together, these studies suggest that autism is associated with regionally specific differences in cortical gyrification that also vary across age. Figures 1, 2D.

2.5. Gray-white matter tissue contrast

The GWC characterizes difference in signal intensities of gray and white matter tissue measured using in vivo sMRI. It is frequently used to identify the gray/white matter boundary and is also relevant to other neuroanatomical imaging markers (e.g., surface area) that rely on the correct placement (i.e., identification) of the lower (i.e., white matter) boundary of the cortex. Notably, the GWC has both methodological [e.g., the variability in field strength, pulse sequence, and data processing parameters (Han et al., 2006)], and biological [e.g., variability across age, regions, and medical conditions (Panizzon et al., 2012)] origins. In neurotypicals, the GWC is reported to show regionally specific decreases. These decreases begin in childhood, are strongest in adolescence, and decelerate in adulthood (Mann et al., 2018). Longitudinal studies in toddlers who later developed autism have reported widespread increases in GWC in frontal, temporal, and parietal regions, where an earlier onset of autism symptoms was associated with slower GWC rates of change (Godel et al., 2021). In autistic adolescents and adults, the GWC was reported to follow an inverted U-shape with a peak in late adolescence (Mann et al., 2018). Thus, region- and age-dependent differences in GWC may be a characteristic hallmark of atypical brain development in autism. Figures 1, 2E.

Taken together, previous cross-sectional and longitudinal studies have examined neuroanatomical features in both the neurotypical and atypical (autistic) brain; and identified age- and region-specific variation in several of these features in autism. In the following section, we will detail the potential neurobiological and/or histological correlates of these neuroanatomical features.

3. Neurobiological underpinnings of different neuroanatomical features

Commonly used approaches to study (neuropathological) mechanisms in humans are largely based on the analysis of postmortem brain tissue (for a review, see Fetit et al., 2021). Among many others, these techniques include (1) microscopic histology [e.g., used to determine cell numbers, types, and sizes (Courchesne et al., 2011b)]; (2) in situ hybridization [e.g., used to determine enzyme levels (Yip et al., 2009)]; (3) metabolomics [e.g., used to probe metabolic pathways (Kurochkin et al., 2019)]; and (4) microanalysis and western blotting [e.g., used to examine receptor densities (Purcell et al., 2001)]. Combined, these approaches have been applied in previous studies to characterize the neurotypical neurobiological associates of the aforementioned neuroimaging features; as well as differences in these underpinnings that may lead to atypical neuroanatomy in autism. In the following, we will briefly outline the current state of this literature. Specifically, we will review general cortical development in neurotypicals and in autism; and the potential neurobiological correlates of individual features.

Broadly, the central nervous system develops from the neuroepithelium, which forms the neural plate and, later, the neural tube. At the start of neurogenesis [∼ gestational week four (Douet et al., 2014)], neuroepithelial cells generate a range of cells (including more neuroepithelial and radial glia progenitor cells) (Huttner and Kosodo, 2005). This generation of cells leads to a thickening of the cortical wall, giving rise to distinct zones (ventricular zone, subventricular zone, subplate/intermediate zone, cortical plate, and marginal zone) (Penisson et al., 2019). Prior to 6 weeks of gestational age, radial glia in the ventricular zone are thought to self-renew through symmetric cell division (amplification) (Penisson et al., 2019). At approximately 6 weeks of gestational age, however, radial glia transition to asymmetric division, resulting in an undifferentiated daughter stem cell (which undergoes further replication), and a progenitor cell that can divide and generate neurons in the subventricular zone (Noctor et al., 2001). At approximately 12–20 weeks (Volpe, 1981), according to the radial unit hypothesis (Rakic, 1978), neurons generated at the same site within the ventricular zone migrate along the radial glial progenitor cells (RGP) to form radial units (ontogenetic columns), with later generated neurons bypassing earlier generated neurons, creating an inside-out gradient of neurogenesis (Rakic, 1978). This developmental process is characteristic of pyramidal cells, which represent the majority (∼75–89%) of neurons in the cortex (Jones, 1984), and it is estimated that 87–90% of cells follow this path (Rakic, 1972). Other pathways exist, e.g., for interneurons, which follow a tangential migratory path to their target layer (Kriegstein and Noctor, 2004). However, these pathways are thought to have only minor effects on the development of cortical layers (Kriegstein and Noctor, 2004), and are beyond the scope of this review. This initial generation of a vast number of neurons is accompanied by gliogenesis (beginning at around gestational week 12) and followed by a period of both synaptogenesis and apoptosis [from around gestational week 20 until 4 years of age (Douet et al., 2014)], extensive arborization and myelination [both from gestational week 20 (Douet et al., 2014)], and pruning [from ∼12–25 years of age (Douet et al., 2014)]. In autism, disruptions in these processes can therefore result in numerous microstructural differences in the brain, that include ectopia/heterotopia, misoriented neurons, irregular lamination, increased neuron numbers, decreased neuron size, and other alterations (Wegiel et al., 2010; Chen et al., 2015). At the macroscopic level, these differences in turn give rise to atypical cortical thickness, surface area, cortical volume, lGI, and the GWC, as outlined in the following.

3.1. Cortical thickness

Cortical thickness, according to the radial unit hypothesis, is initially determined by the output of intermediate progenitor cells (i.e., the number of neurons) within each ontogenetic column (Rakic, 1978). Following an initial increase, and a peak at ∼1–2 years of age, cortical thickness declines progressively until adulthood (Huttenlocher, 1979; Fjell et al., 2015). This decline is thought to reflect extensive synaptic pruning, leading e.g., to a reduction in dendritic spine density and, subsequently, cell volume (Petanjek et al., 2011; Vidal-Pineiro et al., 2020). In autism, increased cortical thickness during childhood may e.g., result from excess neurons (possibly due to migration or pruning deficits), and a greater dendritic spine density and resulting number of synapses and neuronal size (Tang et al., 2014; Khundrakpam et al., 2017). In contrast, accelerated cortical thinning from adolescence onward has been suggested to result from an initial delay in synaptic/axonal pruning, which is thought to lead to a subsequent greater-than-normal neural loss (Lewis and Elman, 2008; Tang et al., 2014).

3.2. Surface area

Surface area, in contrast, is traditionally thought to be driven by the early amplification of radial glia, i.e., the amount of proliferative units and therefore the number of ontogenetic columns (Rakic, 1978), which likely correspond to the minicolumns observed in the adult brain (Krmpotić-Nemanić et al., 1984). Additionally, surface area may be influenced by, and influence other, cortical features. For instance, the expansion of the cortical sheet within the finite volume of the skull suggests a biological link between surface area and gyrification, although the direction of causality remains to be clarified. Surface area may also be influenced by factors that are inherent to the sMRI signal; for instance, as surface area is measured along the white matter surface, a blurring of the gray-white matter boundary may influence reliable surface area estimates (Storsve et al., 2014). Recently, emerging evidence also suggests that surface area measures may be related to the myelination of cortico-cortical axons (Cafiero et al., 2019). For instance, white matter growth may induce a tangential stretching of the brain, leading to an increase in surface area (Seldon, 2005). Alternatively, usage- or learning-dependent pruning (Bourgeois et al., 1994) and a proliferation of myelin into the neuropil (Sowell et al., 2003) have been proposed to influence surface area. Combined, these factors may lead to a rapid expansion of the cortex in childhood/adolescence, and a subsequent decline in the typically developing brain (Raznahan et al., 2011b; Hogstrom et al., 2013; Lyall et al., 2015). In autism, however, even minor disruptions to these crucial developmental processes, especially during the first 6 weeks of development, e.g., in the duration of divisions producing intermediate progenitor cells, may have profound impacts on the brain’s microstructure (White et al., 2010). Similarly, disturbances in white matter development [e.g., reviewed in Ecker (2017)] and synaptic pruning deficits (Tang et al., 2014) may contribute to the atypical expansion of the cortical surface in autism.

3.3. Cortical volume

Cortical volume is regulated through the interplay of the neurodevelopmental mechanisms that modulate its constituent components, namely cortical thickness and surface area. Hence, the neurobiological mechanisms affecting cortical volume development are complex, and inherently difficult to describe. Moreover, as mentioned above, the relative contributions of cortical thickness and surface area to cortical volume may vary across developmental stages; and may exert region-dependent effects (Im et al., 2008; Hazlett et al., 2011; Storsve et al., 2014). We therefore refer the reader to the mechanisms underpinning cortical thickness and surface area, which also affect measures of cortical volume, while highlighting the complex nature of this particular cortical feature.

3.4. Gyrification

The lGI captures the degree of regional folding (gyrification) of a certain brain area (or within a cortical patch). Gyrification, i.e., the formation of gyri and sulci, commences at 10–15 weeks of life, generating an adult-like pattern by the third trimester (Naidich et al., 1994). There are several explanations for cortical gyrification, which can be split broadly into two categories. First, tension-based or mechanical theories posit that gyrification results from the force of cortical fibers pulling together interconnected regions (e.g., Van Essen, 1997). Second, theories of differential tangential expansion suggest that cortical gyrification results from cortical layers/regions undergoing differential growth. Specifically, the difference in expansion of outer, relative to inner, layers may lead to a “buckling” and the generation of gyri and sulci (e.g., Retzius, 1891; Ronan et al., 2014). As mentioned above, gyrification and surface area (and cortical volume) are inherently linked as both need to be contained within the limited space of the skull. Hence, an initial increase in gyrification (White et al., 2010) may (at least partly) be driven by the processes that also help shape surface area and cortical volume (White et al., 2010). Similarly, the subsequent decline in gyrification during adulthood (Magnotta et al., 1999) has been linked to a concomitant accelerated decline in cortical volume during this time (Courchesne et al., 2011a), which may be driven by synaptic pruning (White et al., 2010). Accordingly, atypical gyrification in autism likely results from complex disruptions in the development of surface area, cortical volume, white-matter fibers (Ecker, 2017), neuronal generation and migration (Wegiel et al., 2010), and pruning (Tang et al., 2014). Nonetheless, further studies are needed to provide conclusive evidence on the developmental origins of the biological factors influencing the lGI in both the neurotypical and autistic brain.

3.5. Gray-white matter tissue contrast

The GWC is initially determined by the finely tuned patterning (acquisition of distinct cell identities) and spatial organization of cells and their components during development. In neurotypicals, fully migrated neurons in the cortical plate begin to elaborate dendritic and axonal elements from mid gestation through infancy (Haynes et al., 2005; Huang et al., 2006). These elements rapidly elongate, extending from the intermediate zone to intra- and subcortical targets to form synaptic connections (Haynes et al., 2005; Huang et al., 2006). The resulting groupings of somas (gray matter) and axons (white matter) possess different magnetic properties, which generate the signal contrast captured by sMRI. Accordingly, in the typically developing brain, changes e.g., in myelination and/or neuronal density across age may lead to a reduction in the GWC from childhood onward (Salat et al., 2009; Mann et al., 2018). In autism, increased GWC during childhood (Godel et al., 2021) and an atypical GWC developmental trajectory (in an inverted U-shape) during adolescence and adulthood (Mann et al., 2018) are likely to result from differences in either gray or white matter properties. This may include disruptions in the generation, differentiation, migration, and apoptosis of neurons, as well as the formation of axons. For instance, incomplete migration of intermediate progenitor cells into the cortical plate is thought to result in supernumerary neurons in the subplate and lead to a “blurring” of the gray-white matter tissue boundary (Bailey et al., 1998; Hutsler et al., 2007; Avino and Hutsler, 2010). Also, deficient apoptosis of subplate neurons that guide neurodevelopment may lead to greater retention of transient cells, further contributing to a blurrier boundary (McConnell et al., 1994). Taken together, variation in both gray and white matter may contribute to variation in the GWC; and further studies are required to dissect their relative contributions in the neurotypical and autistic brain.

4. Genetics

Surface-based neuroanatomical measures and their underlying (pathological) neurobiological processes are regulated through genetic and environmental factors, as well as gene-gene and gene-environment (epigenetics) interactions. Here, we will focus on genetic factors, which are thought to explain the majority of brain morphology [estimated heritability: 60–80% (Jansen et al., 2015)]. For reviews of environmental modulators and their interaction with genetic factors, see e.g (Tordjman et al., 2014; Hegarty et al., 2020).

Multiple commonly used statistical approaches exist to assess the genetic correlates of neuroanatomy and its associated biological processes. For example, single variant approaches examine genetic underpinnings (e.g., of a neuroanatomical feature) within a candidate gene framework focusing on functionally characterized polymorphisms (Bogdan et al., 2017) that are identified e.g., through Genome-Wide Association Studies (GWAS). Similarly, linkage studies can be used to identify loci that are associated with phenotypic traits within families (Dawn Teare and Barrett, 2005). Polygenic approaches be used to evaluate the additive effect of many genetic factors that may differ in their association with a trait. For instance, they include (1) polygenic risk scores (PRS), which summarize an individual’s genetic liability to a phenotype (e.g., a trait or a diagnostic label); and (2) biologically informed multilocus profile scores (BIMPS), which summarize polymorphisms across a given neural system to derive a composite of relative signaling within that pathway (Bogdan et al., 2017). To examine joint genetic variation within proteins/interactive networks in a hypothesis-driven or exploratory fashion, researchers may further use system- and pathway-level (enrichment) analyses (Bogdan et al., 2017). Finally, the additive effect of (these) genetic factors (A), common or shared environmental (C), and unique environmental factors and measurement errors (E) on phenotypes can be explored using multivariate approaches (e.g., ACE) (Douet et al., 2014). These approaches rely on various tools, including those that permit sequencing of the whole exome (all protein-coding genes), whole genome (including non-coding regions), single cells (genome and transcriptome of individual cells), and RNA (examines how each protein-coding gene is utilized in a given cellular context). Additionally, epigenetic tools exist that permit the quantification of DNA methylation (e.g., bisulfite sequencing), histone modification (e.g., chromatin immunoprecipitation), and chromosomal interactions that influence gene expression (e.g., chromosome conformation capture) (for a review, see e.g., Bae et al., 2015).

In combining these approaches, previous studies have explored the link between genetic variation and inter-individual variability in neuroanatomy indirectly (e.g., via the neurobiological mechanisms outlined above). Taken together, these studies have identified genetic and transcriptomic variation that converges in several key biological pathways, which may jointly influence cortical thickness, surface area, cortical volume, the local gyrification index, and the GWC. Further, emerging evidence, facilitated by progress in neuroimaging and statistical approaches, is examining the specific genetic factors contributing to neuroanatomical variability directly. In the following, we will provide an overview of the current state of research in both the neurotypical and autistic brain.

4.1. Genetic influences on neuroanatomy in neurotypicals

In the neurotypical brain, neuroanatomy and its development [beginning 2 weeks post-conception (Douet et al., 2014)] are largely regulated by genetic factors. This is highlighted by the fact that the reported heritability [i.e., the proportion of phenotypic (observable) variation in a trait that can be attributed to inherited genetic factors] of gray matter volume is greater than 50% overall [56% in neonates (Gilmore et al., 2010) and 82% in adults (Baaré et al., 2001), as summarized in Douet et al., 2014]. This heritability is thought to arise from the additive effect of hundreds of small-effect SNPs that are distributed across the entire genome (Toro et al., 2015). For example, GWAS studies have highlighted the relevance of (1) the COMT Va158Met polymorphism for cortical thinning from 9 to 22 years of age (Raznahan et al., 2011a), and (2) the 5-HTTLPR polymorphism in white matter microstructure in adolescents and adults (Pacheco et al., 2009). Also, previous studies have stressed sexual dimorphisms and the potential role of sex chromosomes in determining neuroanatomy and its development [e.g., reviewed in Douet et al., 2014]. Thus, while many findings await replication, emerging literature is implicating an increasing number of genes in the formation of brain structure.

Notably, the influence of these genes may vary across brain regions. For instance, a study in neurotypicals highlighted regional heterogeneity in the magnitude of genetic influence on cortical thickness (Rimol et al., 2010). Further, the role of these genes, and their expression in particular cell types, may change across age (Ball et al., 2020). This variability may be the result of various epigenetic factors, such as DNA methylation, histone modifications, microRNAs, and long noncoding RNAs (Douet et al., 2014). In fact, it is estimated that one third (i.e., 10,000 genes) of the whole genome is expressed solely during development (Johnson et al., 2009; Zhang et al., 2011); and that the rate of gene expression changes rapidly during fetal development, decelerates throughout childhood and adolescence, stabilizes in adulthood, and accelerates again after 50 years of age (Colantuoni et al., 2011). Moreover, gene expression patterns are thought to have a reverse relationship, whereby genes with the lowest expression during fetal development are highly expressed during aging and neurodegeneration and vice versa (Colantuoni et al., 2011; Douet et al., 2014). In sum, (the development of) neuroanatomy is tightly regulated through time-sensitive (epi)genetic influences. Consequently, neurodevelopmental conditions such as autism have been associated with alterations in the (epigenetic control of) genetic variation that contributes to neuroanatomy and its development.

4.2. Genetic influences on neuroanatomy in autism

In autism, differences in neuroanatomy have also been linked to genetic factors, although heritability estimates may differ from those in neurotypicals (Hegarty et al., 2020). Evidence for a potential genetic regulation of neuroanatomy in autism comes from a wealth of studies that have identified common and rare (epi)genetic variation in ∼1,000 genes (O’Roak et al., 2012). Combined, this variation may converge in the disruption of processes that are crucial to (the development of) neuroanatomical features. These processes include e.g., chromatin remodeling, Wnt signaling during development, and synaptic processes (De Rubeis et al., 2014; Krumm et al., 2014); as well as other pathways [e.g., disturbed protein synthesis and degradation, (mTOR-related) cell metabolism etc., reviewed in Bourgeron, 2015 and de la Torre-Ubieta et al., 2016] that are beyond the scope of this review. Similarly, for a comprehensive study of the genetic effect on neuroanatomy of multiple genetic mouse models of autism, we refer the reader to previous work (e.g., Ellegood et al., 2015).

Chromatin modification can influence early neuroanatomical development, e.g., by altering the expression of genes regulating the fate of neuronal progenitor cells [proliferation, neuronal lineage commitment and differentiation (Lasalle, 2013; Cotney et al., 2015)]. Consequently, its disturbance may affect the establishment of neurotypical neuroanatomy. In autism, examples of reported chromatin-related anomalies include mutations in genes encoding chromatin modifiers and regulators and transcription factors, such as MECP2, CHD8, ARID1B, CBX4, KDM6B, MLL3/5, SMARCC2, SETD2, MEF2A etc (O’Roak et al., 2012; Ben-David and Shifman, 2013; Parikshak et al., 2013; Bourgeron, 2015; Sahin and Sur, 2015). Other examples include genetic variants that are located outside of protein coding exons, but influence the binding and actions of chromatin factors and DNA methylation patterns (Lasalle, 2013). Wnt signaling may help shape neuroanatomy e.g., by regulating radial glia self-renewal, neurogenesis, and neuronal differentiation (Hansen et al., 2011; Tiberi et al., 2012). Accordingly, overexpression of β-catenin, a key component of the Wnt canonical pathway, has been reported to lead to a drastic expansion of cortical surface area and thinning of the cortex (Chenn and Walsh, 2002; Wrobel et al., 2007). In autism, genetic variation associated with Wnt signaling includes, e.g., CTNNB1, which encodes β-catenin (Krumm et al., 2014); DLL1, which is expressed in neural progenitor cells (Barton and Fendrik, 2013); and TBL1XR1, which binds β-catenin (Cadigan, 2008). Last, previous studies in autism have highlighted synaptic genes (Voineagu et al., 2011; de la Torre-Ubieta et al., 2016), which may affect neuroanatomy e.g., by altering dendritic arborization and spine density. In autism, atypical synaptic genes include those associated with synaptic cell adhesion molecules like neurexins [e.g., NRXN2 and NRXN3 (Wang et al., 2018)] and neuroligins [e.g., NLGN3, NLGN4 (Jamain et al., 2003)]; synaptic scaffolding molecules [e.g., SHANK3 (De Rubeis et al., 2014)]; synaptic receptors and transmitters [e.g., GABRB3 (Buxbaum et al., 2002), GluR6 (Jamain et al., 2002)], and HTT (locus SLC6A4), which encodes the serotonin transporter (Tordjman et al., 2001); and ion channels [e.g., SCN2A, encoding NAV1.2 channels; CACNA1D, encoding the CAV1.3 channel; and CACNA2D3, encoding the α2δ-3 subunit (De Rubeis et al., 2014)].

Notably, these processes are heavily interlinked (epistasis). For example, chromatin-related genes, such as CHD8, are thought to help shape regulatory expression networks in the developing brain; and to influence other autism risk/liability genes (Cotney et al., 2015), such as p53, a regulator of apoptosis (Nishiyama et al., 2009), and the Wnt/β-catenin target genes (Lasalle, 2013). This underscores the pleiotropy of many autism genes, whereby variations in certain genes (some of which appear to affect other genes) result in a wide range of phenotypic expressions (Lee et al., 2021). Conversely, many autism-related genetic anomalies also converge onto common pathways that jointly affect cortical development, chromatin modification, Wnt signaling, and synaptic functioning (Hashem et al., 2020), and therefore influence neuroanatomical features like cortical thickness and surface area (van der Meer et al., 2020). Further, genetic influences on neuroanatomy may be region-specific. For instance, previous studies suggest that physically adjacent brain regions display positive genetic correlations (e.g., for cortical thickness and surface area), while more distal regions are negatively correlated (Grasby et al., 2020). Also, the penetrance and phenotypic expression of genetic variants may vary, e.g., as reported in probands with copy number variants in NRXN1, which showed no clinically overt brain-related phenotype (Woodbury-Smith et al., 2017).

In sum, neuroanatomy has been associated with a wealth of genomic factors that may further interact; and whose disruptions (e.g., in autism) may give rise to atypical neuroanatomy and neuroanatomical development. In the following, we will briefly review the existing literature on how genomic factors may influence individual cortical features in the neurotypical and atypical (autistic) brain.

4.3. Genetic influences on cortical thickness

In neurotypicals, estimates of how much variance in cortical thickness is determined by genetic factors vary across studies [e.g., average cortical thickness: 26% (Grasby et al., 2020); regional cortical thickness: 13% (Grasby et al., 2020); heritability: 69–81% (Panizzon et al., 2009; Winkler et al., 2010)]. Nonetheless, several studies have associated neuroanatomical variability in cortical thickness with common and rare variants. For instance, in a large-scale study including participants ranging from childhood to old age, average cortical thickness was linked to RPSA, which is associated with laminin, a regulator of neurogenesis, neuronal differentiation, and neuronal migration (Solozobova et al., 2012; DiGiacomo and Meruelo, 2016); and ACTR1B, which helps modulate the dynactin complex involved in neuronal migration (Itoh, 2016). Notably, variability in cortical thickness was enriched for active regulatory elements (promoters and enhancers) that are adult-specific and influence processes such as myelination, pruning, and branching (Grasby et al., 2020). Evidence from a large-scale GWAS (Hofer et al., 2020) has further linked regional variability in cortical thickness to variation in pathways associated with autism, including Wnt signaling (e.g., WNT3, DAAM1) and transcription (e.g., SALL1). Further, studies in individuals ranging from childhood to old age reported that cortical thinning was associated with interregional patterns not only of neuronal, but also of glial gene expression (Shin et al., 2018; Vidal-Pineiro et al., 2020). Neuronal gene expression included markers of CA1 pyramidal cells, e.g., ADGRB3, involved in synaptic functioning (Sticco et al., 2021); CDH2, implicated in neuronal differentiation (Alimperti and Andreadis, 2015); and CHL1, aiding neuronal survival (Chen et al., 1999). Glial gene expression comprised genes associated with microglia, e.g., ALOX5, involved in synaptic function (Joshi et al., 2014); and BLNK and CYBB, both implicated in immune function (Rae et al., 1998; Minegishi et al., 1999). It also included astrocytic genes, such as ALDH5A1, an indirect regulator of GABA catabolism (DiBacco et al., 2020); and ASTN1, a promoter of neuronal migration (Horn et al., 2018). Less thinning was associated with greater gene expression in development. Moreover, this relationship was reversed during aging (Vidal-Pineiro et al., 2020). This further highlights the temporal specificity of the genetic regulation of neuroanatomy. Moreover, in neurotypical children, greater cortical thickness was associated with greater polygenic scores for autism (Grove et al., 2019; Khundrakpam et al., 2020). Studies of rare variants further reported that, in neurotypical children and adolescents, reduced cortical thickness in “social brain” regions, and greater autism symptomatology [increasing scores on the Social Responsiveness Scale (SRS) (Constantino et al., 2003)], were associated with greater variation (G->C allele) in the MET receptor tyrosine kinase promotor (Campbell et al., 2006; Hedrick et al., 2012). MET is thought to help regulate synaptogenesis, and migration and is also an autism risk gene (Campbell et al., 2006; Hedrick et al., 2012). In line with this, we have previously reported that variation in cortical thickness (development) in brain regions associated with autism (core) symptoms was genetically enriched for a range of genes implicated in autism, including those involved in (excitatory) synaptic transmission and development (Bieneck et al., 2021; Ecker et al., 2022). Combined, these studies further underscore a link between atypical neuroanatomy and genetic disruptions, even in the absence of a clinically manifested diagnosis Table 1.

TABLE 1.

The genetic influences on neuroanatomy in neurotypicals (NT genes) and individuals with autism (Autism genes), and their functional roles, that are mentioned in this review.

NT genes Association References Autism genes Association References
CT
RPSA Laminin, neurogenesis, neuronal differentiation, and neuronal migration DiGiacomo and Meruelo, 2016 SCN1A Voltage-gated sodium channels Weiss et al., 2003
ACTR1B Modulates the dynactin complex involved in neuronal migration Itoh, 2016 SLIT1, SLIT3 Axonal midline crossing Plump et al., 2002
WNT3 Wnt signalling Hofer et al., 2020 GABRA3, GABRA5 GABA receptor subunit Parikshak et al., 2016
DAAM1 Wnt signalling Hofer et al., 2020 GABRB1 GABA receptor subunit Parikshak et al., 2016
SALL1 Transcription Hofer et al., 2020 PTCHD1 Excitatory synapses Ross et al., 2020
ADGRB3 Synaptic functioning Sticco et al., 2021 SYN2 Synapsin 2 Corradi et al., 2014
CDH2 Neuronal differentiation Alimperti and Andreadis, 2015 SYT17 Synaptotagmin 17 Ruhl et al., 2019
CHL1 Neuronal survival Chen et al., 1999 FMR1 Fragile X messenger ribonucleoprotein DiMario, 2004
ALOX5 Microglia, synaptic functioning Joshi et al., 2014 TSC1 Neuronal growth and migration Fu et al., 2012
BLNK Immune function Minegishi et al., 1999
CYBB Immune function Rae et al., 1998
ALDH5A1 GABA catabolism DiBacco et al., 2020
ASTN1 Neuronal migration Horn et al., 2018
MET Synaptogenesis, migration Campbell et al., 2006; Hedrick et al., 2012
SA
INA Neuronal migration Baum and Garriga, 1997 BDNF Neuronal proliferation and plasticity Raznahan et al., 2009
AS3MT Neural plasticity Zhao W. et al., 2021
NT5C2 Neural progenitor cells Duarte et al., 2019
EIF2AK4 Synaptic plasticity, neuritogenesis Roffé et al., 2013
THBS1 Synaptogenesis Jayakumar et al., 2014
ST7L Wnt pathway Savage et al., 2018
WNT2B Wnt pathway Savage et al., 2018
NSF Synaptic transmission Nishimune et al., 1998
RSPO3 Wnt signalling Katoh and Katoh, 2017
FOXO3 Cell survival and apoptosis Pino et al., 2014
CV
IGFBP7 Learning, memory, neurogenesis Xia et al., 2017 SLC6A4 Serotonin transporter gene Katoh and Katoh, 2017
ZNF804A Zinc finger protein Wei et al., 2015 BDNF Brain-derived neurotrophic factor Baum and Garriga, 1997
DAAM1 Histone modification van der Lee et al., 2019; Hofer et al., 2020 OXTR Oxytocin receptor Pino et al., 2014
THBS3 Histone modification van der Lee et al., 2019
ZIC4 Transcriptional regulation van der Lee et al., 2019
FGFRL1 Fibroblast growth factor receptor van der Lee et al., 2019
RSPO3 Wnt signalling Hofer et al., 2020
NSF Synaptic transmission Hofer et al., 2020
FOXO3 Cell survival and apoptosis Hofer et al., 2020
Gyrification
SEMA3A Axon guidance Vo et al., 2013 MECP2 Rett syndrome Keidar et al., 2019
ROBO2 Neuronal cell differentiation Sung et al., 2013 LIS1 Lissencephaly Keidar et al., 2019
NAV2 Neuronal migration Pook et al., 2020; van der Meer et al., 2021
Gyrification
SEMA3A Axon guidance Vo et al., 2013 MECP2 Rett syndrome Keidar et al., 2019
ROBO2 Neuronal cell differentiation Sung et al., 2013 LIS1 Lissencephaly Keidar et al., 2019
NAV2 Neuronal migration Pook et al., 2020; van der Meer et al., 2021
GWMC
MIR137 (RNA gene) Development, differentiation The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium, 2011
CACNAC1C Calcium channel signaling The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium, 2011
ANK3 Cell activation, proliferation The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium, 2011
ITIH3-ITIH4 The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium, 2011
VCAN Early cell remodeling Wathlet et al., 2011
NBEAL1 Fetal development Chen et al., 2004
CACNB2 Cortical thickness Chen et al., 2020

Please note that this list is not comprehensive. For comprehensive reviews of genetic factors implicated in autism, see e.g (Woodbury-Smith and Scherer, 2018; Wiśniowiecka-Kowalnik and Nowakowska, 2019). CT, cortical thickness; CV, cortical volume; GWMC, grey-white matter tissue contrast; SA, surface area. Findings highlighted in grey did not replicate in follow-up studies (Papiol et al., 2014).

In autism, recent progress in the availability of large-scale datasets is now enabling research into how atypical cortical thickness (development) is influenced by common genetic variation. For example, in autistic children, global cortical thickness differences were enriched for variation in genes downregulated in autism (Parikshak et al., 2016). Among others, these comprised genes involved in neurodevelopment and the regulation of synaptic processes. They included SCN1A, which encodes voltage-gated sodium channels (Weiss et al., 2003); SLIT1 and SLIT3, which help regulate axonal midline crossing in the developing brain (Plump et al., 2002); GABRA3, GABRA5, and GABRB1, which encode GABA receptor subunits (Parikshak et al., 2016); PTCHD1, which helps regulate excitatory synapses (Ross et al., 2020); and SYN2 and SYT17, which encode synapsin 2 and synaptotagmin 17, respectively, and regulate synaptic functioning (Corradi et al., 2014; Ruhl et al., 2019). Also, a recent study in children, adolescents, and adults reported that deviations in cortical thickness from the neurotypical developmental trajectory were associated with polygenic risk for autism (Ecker et al., 2022). Moreover, regional differences in cortical thickness were enriched for genes (both common and rare variants) previously associated with autism, including those involved in cell differentiation, synaptic functioning, transmembrane receptor activity, synaptic transmission, cell adhesion signaling, and nuclear functioning (Voineagu et al., 2011; Parikshak et al., 2016; Gandal et al., 2018). Regions where autism subgroups differed in sensory processing were further enriched for genes linked to the (migration of) excitatory neurons, including in deep layer 1 and 2 (Polioudakis et al., 2019; Ecker et al., 2022); highlighting potential within-group variability in the relationship between neuroanatomy and genetic variation in autism. Previous research has also examined how cortical thickness is impacted by rare genetic variants. For instance, studies have identified atypical cortical thickness in common single-gene conditions associated with autism, such as Fragile X Syndrome (Shelton et al., 2016); where atypical methylation of FMR1 contributes to disruptions in brain development; and Tuberous sclerosis (DiMario, 2004), where variation e.g., in TSC1 has been linked to a disruption in neuronal growth and migration (Fu et al., 2012). Combined, these studies provide strong evidence for the notion that inter-individual variation in genes (including those involved in biologically plausible pathways implicated in autism) is linked to atypical cortical thickness (development) in autism Table 1.

4.4. Genetic influences on surface area

In the typically developing brain, surface area is thought to be determined primarily by genetic factors, although heritability estimates vary across studies [e.g., 71–89% (Panizzon et al., 2009; Winkler et al., 2010)]. Among these genetic determinants, common genetic variants may explain up to 34% of variance in total, and 8–31% in regional, surface area (Grasby et al., 2020). In line with this, a recent large-scale study has linked total surface area variability to multiple genetic variants, such as INA, which is associated with neuronal migration (Baum and Garriga, 1997); AS3MT, related to neural plasticity (Zhao W. et al., 2021); and NT5C2, linked to signaling in neural progenitor cells (Duarte et al., 2019). The same study linked regional surface area variability to variants including EIF2AK4, which is associated with synaptic plasticity and neuritogenesis (Roffé et al., 2013); THBS1, a modulator of synaptogenesis (Jayakumar et al., 2014), and many single nucleotide polymorphisms (SNPs) related to the Wnt pathway, such as ST7L and WNT2B (Savage et al., 2018). Similarly, evidence from a large-scale GWAS (Hofer et al., 2020) has linked both global and regional surface area variability to variation in genes involved synaptic transmission (e.g., NSF) (Nishimune et al., 1998), Wnt signaling (e.g., RSPO3) (Katoh and Katoh, 2017), and cell survival and apoptosis (e.g., FOXO3) (Pino et al., 2014). Notably, variation in surface was associated with genetic variants that alter regulatory activity in neural progenitor cells during fetal development (unlike cortical thickness, where enrichment was adult-specific) (Grasby et al., 2020). Combined, this suggests that both total and regional surface area are influenced by (time-sensitive) genetic variation in pathways that contribute to the phenotype of surface area; and that atypical surface area may therefore reflect variation in these genetic correlates Table 1.

In autism, surface area is also thought to be largely heritable (Hegarty et al., 2020), but little is known about the specific genetic contributions to this morphometric measure. Among the relatively few studies examining the relationship between surface area and genetic variation in autism (compared to neurotypicals), a previous study in children, adolescents, and adults reported that frontal surface area and cortical volume were regulated differently by a single nucleotide polymorphism in BDNF (BDNF Val66met genotype) (Raznahan et al., 2009). BDNF helps regulate neuronal proliferation and plasticity (Raznahan et al., 2009), and may therefore plausibly influence surface area. Further, we have previously shown that in autism, surface area in brain regions associated with variation in adaptive outcome were enriched for (1) genes commonly downregulated in autism (Gandal et al., 2018) (OR = 3.07), (2) co-expression modules downregulated in autism (Parikshak et al., 2016), and (3) genes differentially expressed in bipolar disorder and schizophrenia (Gandal et al., 2018; Pretzsch et al., 2022). Last, altered surface area has also been identified in conditions genetically and clinically associated with autism, such as 16p11.2 deletion and duplication syndromes (Qureshi et al., 2014). Combined, these studies suggest that there may be clinical/biological subgroups in autism which display distinct relationships between (altered) neuroanatomy and genetic variation Table 1.

4.5. Genetic influences on cortical volume

In neurotypicals, cortical volume (like its components cortical thickness and surface area) is thought to be determined largely (up to ∼90%) by genetic factors (Baaré et al., 2001; Wallace et al., 2006). For instance, in neurotypical infants, brain volume has been shown to be associated with variation in IGFBP7, which may be linked to learning, memory, and neurogenesis (Xia et al., 2017). Moreover, in adults, cortical volume (and surface area) in frontal, precentral, and parietal regions was linked to variation in the ZNF804A gene (Wei et al., 2015). A recent large-scale study further suggests that the genetic influence on cortical volume may differ across regions; in fact, volumes of individual lobes were associated with specific genetic variants located in regions enriched for histone modifications (DAAM1 and THBS3) and close to genes causing Mendelian brain-related diseases (ZIC4 and FGFRL1) (van der Lee et al., 2019). Given that cortical volume is the product of cortical thickness and surface area, it is unsurprising that the genetic correlates of these features (e.g., DAAM1, RSPO3, NSF, and FOXO3) overlap (Hofer et al., 2020). In sum, the existing research indicates that the link between cortical volume and genetic variation may be region-specific (and potentially age-dependent); and additional research is required to elucidate the mechanisms that regulate these relationships Table 1.

In autism, cortical volume is thought to be determined largely by genetic factors (Hegarty et al., 2020); but few studies have identified individual rare, let alone common, genetic contributors to cortical volume in autistic people. In children, adolescents, and adults, we have previously reported that cortical volume differences in clinical outcome-related regions were enriched for (common and rare) gene sets that are downregulated in autism (Gandal et al., 2018) and co-expression modules upregulated in autism (Parikshak et al., 2016). Also, in autistic children, atypical cortical gray matter volume has been associated with 5-HTTLPR, a promoter of the serotonin transporter gene SLC6A4 (Wassink et al., 2007). A study in adolescents and adults found that frontal cortical volume was regulated atypically in the BDNF val66 met genotype (Raznahan et al., 2009). In autistic adults, atypical cortical volume in the insula was linked to variation in OXTR, the oxytocin receptor gene (Saito et al., 2014). Combined, these studies provide preliminary evidence that cortical volume disruptions may be related to genetic variation in (biologically plausible) pathways that influence the cortical volume phenotype; but little is known about the (distinct) cortical thickness- and surface area-linked genetic and biological contributors to this relationship Table 1.

4.6. Genetic influences on gyrification

In neurotypicals, gyrification (unlike other morphological features) has been reported to be determined largely by non-genetic factors (Hegarty et al., 2020; Schmitt et al., 2021); and the (limited) influence of genetic factors on gyrification may vary across the brain (Pizzagalli et al., 2020; Schmitt et al., 2021). Further, a recent study in neurotypical adolescents and adults, has linked cortical folding to patterns of local genetic correlations in cortical thickness. More specifically, the authors suggested that cortical folding may be due to patterned local influences on cortical thickness that may reflect e.g., molecular signaling gradients and cellular variation (Alexander-Bloch et al., 2020). Similarly, a recent study (van der Meer et al., 2021) highlighted significant genetic overlap between gyrification (sulcal depth), cortical thickness, and surface area. The study also identified multiple genetic loci linked directly to cortical folding (sulcal depth), including e.g., SEMA3A, which is involved in axon guidance (Vo et al., 2013); ROBO2, linked to (neuronal) cell differentiation (Sung et al., 2013); and NAV2, which is implicated in neuronal migration (Pook et al., 2020; van der Meer et al., 2021). Combined, these studies suggest that gyrification may be genetically/biologically coupled with other cortical features; but the distinct genetic contributors to each feature, and their relationships with each other, remain unclear Table 1.

In autism, similar to neurotypicals, heritability studies suggest that gyrification is only minorly influenced by genetic factors (Kates et al., 2009); and research into these factors remains scarce to non-existent. For instance, preclinical research studies suggest that MECP2, the main causative gene of Rett syndrome, which is also associated with autism, interacts on a molecular level with LIS1, the main causative gene for lissencephaly (Keidar et al., 2019); suggesting a potential genetic association between gyrification and autism. However, these findings remain to be validated in humans. Moreover, as gyrification is associated with cortical thickness and surface area, it is likely that the genetic factors modulating these features also influence gyrification. For example, according to the tension based on model of gyrification, it is possible that atypical gyrification in autism is (at least partly) modulated by genetic differences in white matter (for a review, see Travers et al., 2012). However, additional research is crucial to identify the genetic influences on cortical gyrification, both in the neurotypical and autistic brain Table 1.

4.7. Genetic influences on gray-white matter tissue contrast

In neurotypical adults, the GWC is thought to be determined (in part) by regionally specific genetic influences [heritability 0.24–0.5 (Panizzon et al., 2012)]. As evident in the name, the contrast depends on the properties of both gray and white matter. However, a recent study in neurotypical adults found no genetic correlation between the GWC and the gray-matter based cortical thickness, suggesting separate sources of genetic variance for these two features (Panizzon et al., 2012); while the genetic correlations between the GWC and surface area remain to be investigated. Similarly, the genetic link between the GWC and white matter remain poorly understood. Previous studies suggest that white matter may be regulated through a complex set of genes, such as MIR137, CACNA1C, ANK3, and the ITIH3-ITIH4 region (The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium, 2011); but efforts to replicate these specific findings have failed (Papiol et al., 2014). Other GWAS (Zhao B. et al., 2021) have identified additional (to be validated) genetic variants underpinning white matter, including VCAN, implicated in early cell remodeling (Wathlet et al., 2011); NBEAL1, implicated in fetal development (Chen et al., 2004); and CACNB2, which has been associated with cortical thickness in bipolar disorder (Chen et al., 2020). Moreover, in neurotypical children, white matter connectivity between frontal and parietal regions was associated with higher autism polygenic scores (Grove et al., 2019; Khundrakpam et al., 2020). Notably, a recent study in eight psychiatric/mental health conditions found that the white matter associated genetic variant DCC (a regulator of white matter projections/axonal guidance during development) was the most highly pleiotropic locus across conditions (Lee et al., 2021). Combined, these studies highlight the biological and genetic complexity of the GWC; and the (potentially) low specificity and high pleiotropy of the implicated genetic variants Table 1.

In autism, the genetic variation influencing atypical GWC remains largely unstudied. Studies in autistic children and adolescents have linked atypical white matter (volume) to mutations in PTEN, which has been associated with neural connectivity, plasticity, and apoptosis (van Diepen and Eickholt, 2008; Frazier et al., 2015). However, additional research is required to examine the genetic correlates of the GWC in this condition.

5. Current and future trends

Taken together, research into the biological and genetic underpinnings of neuroanatomy is rapidly expanding. This work has been facilitated by the emergence of new fields of research (e.g., imaging genomics, which aims to link phenotypic features to associated genomic variation); and novel statistical and technological approaches [e.g., linkage disequilibrium (LD) score based regression, which permits the genetic correlation of different phenotypes while controlling for intrinsic correlation existing between genetic loci in LD blocks (Bulik-Sullivan et al., 2015)]. Combined, this progress has enhanced both data-driven exploratory studies, e.g., aimed at identifying new aetiological mechanisms/variants; and hypothesis-driven research, e.g., seeking to confirm previously implicated neurobiological features. Nonetheless, several limitations remain to be addressed to realize the potential of these approaches. These include frequently restrictive sample sizes, which reduce the power of studies to detect statistically significant effects. For instance, just under 200 participants are required to detect an effect size of 80% at p = 0.01 (in an independent sample t-test), not yet accounting for multiple comparison corrections (Carter et al., 2017). Studies aiming to associate inter-individual differences in brain structure or function with complex cognitive or mental health phenotypes (i.e., brain-wide association studies) may even require thousands of individuals to be reproducible (Marek et al., 2022). These sufficiently large sample sizes are particularly crucial in view of the aetiological and phenotypic heterogeneity in autism and the multitude of examined features (e.g., brain regions or genetic loci).

Another limitation is that replication efforts are frequently hampered (e.g., by practical considerations, such as the lack of an appropriate independent dataset and associated costs) and are therefore often limited to within-sample cross validation etc. Fortunately, several research collaborations and consortia [e.g., EU-AIMS (European Autism Interventions — A Multicenter Study for Developing New Medications) and AIMS-2-TRIALs (Autism Innovative Medicine Studies-2-Trials) (Murphy and Spooren, 2012), ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) (Thompson et al., 2014), the autism genome project (Hu-Lince et al., 2005), R2D2 (Risk and Resilience in Developmental Diversity and Mental Health) with a link to the website: www.r2d2-mh.eu the autism genetic resource exchange (Geschwind et al., 2001), and the UK biobank (Ollier et al., 2005)] are currently underway to tackle these challenges in increasingly large and heterogeneous participant groups. Harnessing technical advances, such as individual-level statistics (e.g., normative modeling approaches) or (cross-modal) clustering techniques (e.g., canonical correlation analysis and principal independent component analysis), these studies are increasingly equipped to parse the aetiological/pathophysiological heterogeneity of autism, and to put new findings into rapidly updated frameworks of pathology. Further, by including diverse groups of participants across age, these studies also permit glimpses into the specificity and commonality of (e.g., aetiological) features to autism and related (co-occurring) conditions. For instance, a recent study in more than 200 children reported neuroanatomical differences in autism that were shared by individuals with attention-deficit/hyperactivity disorder (Kushki et al., 2019).

Combined, this research is crucial not only to elucidate biological mechanisms in autism, but also to help inform clinical practice. For example, the stratification of autistic individuals into neurobiologically homogeneous subgroups may aid the development of interventions tailored to these subgroups (“precision medicine”); for a recent “white paper” regarding the use of biomarkers in precision medicine, (see Beversdorf, 2016). Further, linking imaging features and associated biological mechanisms to clinical outcome may boost future diagnostic processes, which are currently restricted to an assessment of behavior. For example, we have found preliminary evidence that individual- and group-level neuroanatomical variability predict longitudinal clinical outcome associated with core features in autism (Pretzsch et al., 2022). Once validated, such insights into (individual-level) genetic and pathophysiological mechanisms underpinning clinical profiles could provide a basis for (supplementary) diagnostic tools.

6. Conclusion

In this review, we have discussed commonly studied neuroanatomical features and their potential biological mechanistic and genetic underpinnings in the neurotypical and autistic brain. Most of the reviewed studies focused on cortical thickness and surface area; while research into other features (lGI, GWC) and their neurobiological correlates was scarce. Combined, the reviewed literature suggests that neuroanatomical features possess both distinct and shared neurobiological contributors whose variability between regions and across age is regulated dynamically by a complex interplay of epigenetic factors. Examples of distinct contributors include the number of proliferative units (which determines surface area) compared to the number of cells in each unit (which determines cortical thickness) [see radial unit hypothesis (Rakic, 1978)]. However, these contributors may originate from shared pathways, e.g., the development of progenitor cells; and are likely polygenic, i.e., influenced by more than one gene. Shared neurobiological contributors include, e.g., the association of surface area with both cortical volume and gyrification; and the genetic overlap between cortical thickness and surface area (Jha et al., 2018), which underscores the pleiotropy of many (autism) genes. Notably, this aetiological and pathophysiological overlap between imaging features may affect their suitability as an intermediate phenotype to examine underpinning mechanisms in autism. To address this, it is crucial to clearly demarcate the investigated feature; and to chart a potential mechanistic pathway from imaging feature through neurobiological mechanisms to genomic factors to contextualize and interpret findings appropriately. Such efforts are currently being facilitated by several large-scale research collaborations examining large and heterogeneous samples. Combined, these studies may not only improve our understanding of biological mechanisms in autism, but also help stratify individuals to support the development of targeted clinical interventions.

Author contributions

Both authors were involved in the conceptualization, writing, draft preparation, review and editing of the manuscript and read and agreed to the published version of the manuscript.

Acknowledgments

We thank Anthony Ienco, Martina Arenella, and Dori Floris for their support in preparing this manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  1. Alexander-Bloch A., Raznahan A., Vandekar S., Seidlitz J., Lu Z., Mathias S., et al. (2020). Imaging local genetic influences on cortical folding. Proc. Natl. Acad. Sci. U. S. A. 117 7430–7436. 10.1073/pnas.1912064117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alimperti S., Andreadis S. (2015). CDH2 and CDH11 act as regulators of stem cell fate decisions. Stem Cell Res. 14 270–282. 10.1016/j.scr.2015.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen J., Damasio H., Grabowski T. (2002). Normal neuroanatomical variation in the human brain: An MRI-volumetric study. Am. J. Phys. Anthropol. 118 341–358. 10.1002/ajpa.10092 [DOI] [PubMed] [Google Scholar]
  4. American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. DSM-5, 5th Edn. Washington, DC: American Psychiatric Association. [Google Scholar]
  5. Anand S., Mondal A. (2020). Neuroanatomical distribution and functions of brain-derived neurotrophic factor in zebrafish (Danio rerio) brain. J. Neurosci. Res. 98 754–763. 10.1002/jnr.24536 [DOI] [PubMed] [Google Scholar]
  6. Avino T., Hutsler J. (2010). Abnormal cell patterning at the cortical gray-white matter boundary in autism spectrum disorders. Brain Res. 1360 138–146. 10.1016/j.brainres.2010.08.091 [DOI] [PubMed] [Google Scholar]
  7. Baaré W., Hulshoff Pol H., Boomsma D., Posthuma D., de Geus E., Schnack H., et al. (2001). Quantitative genetic modeling of variation in human brain morphology. Cereb. Cortex 11 816–824. 10.1093/cercor/11.9.816 [DOI] [PubMed] [Google Scholar]
  8. Bae B., Jayaraman D., Walsh C. (2015). Genetic changes shaping the human brain. Dev. Cell 32 423–434. 10.1016/j.devcel.2015.01.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bailey A., Luthert P., Dean A., Harding B., Janota I., Montgomery M., et al. (1998). A clinicopathological study of autism. Brain 121 889–905. 10.1093/brain/121.5.889 [DOI] [PubMed] [Google Scholar]
  10. Ball G., Seidlitz J., O’Muircheartaigh J., Dimitrova R., Fenchel D., Makropoulos A., et al. (2020). Cortical morphology at birth reflects spatiotemporal patterns of gene expression in the fetal human brain. PLoS Biol. 18:e3000976. 10.1371/journal.pbio.3000976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barton A., Fendrik A. (2013). Sustained vs. oscillating expressions of Ngn2, Dll1 and Hes1: A model of neural differentiation of embryonic telencephalon. J. Theor. Biol. 328 1–8. 10.1016/j.jtbi.2013.03.004 [DOI] [PubMed] [Google Scholar]
  12. Baum P., Garriga G. (1997). Neuronal migrations and axon fasciculation are disrupted in ina-1 integrin mutants. Neuron 19 51–62. 10.1016/s0896-6273(00)80347-5 [DOI] [PubMed] [Google Scholar]
  13. Bedford S., Park M., Devenyi G., Tullo S., Germann J., Patel R., et al. (2020). Large-scale analyses of the relationship between sex, age and intelligence quotient heterogeneity and cortical morphometry in autism spectrum disorder. Mol. Psychiatry 25 614–628. 10.1038/s41380-019-0420-6 [DOI] [PubMed] [Google Scholar]
  14. Ben-David E., Shifman S. (2013). Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. Psychiatry 18 1054–1056. 10.1038/mp.2012.148 [DOI] [PubMed] [Google Scholar]
  15. Beversdorf D. (2016). Phenotyping, etiological factors, and biomarkers: Toward precision medicine in autism spectrum disorders. J. Dev. Behav. Pediatr. 37 659–673. 10.1097/DBP.0000000000000351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bieneck V., Bletsch A., Mann C., Schäfer T., Seelemeyer H., Herøy N., et al. (2021). Longitudinal changes in cortical thickness in adolescents with autism spectrum disorder and their association with restricted and repetitive behaviors. Genes 12:2024. 10.3390/genes12122024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bogdan R., Salmeron B., Carey C., Agrawal A., Calhoun V., Garavan H., et al. (2017). Imaging genetics and genomics in psychiatry: A critical review of progress and potential. Biol. Psychiatry 82 165–175. 10.1016/j.biopsych.2016.12.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bourgeois J., Goldman-Rakic P., Rakic P. (1994). Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex 4 78–96. 10.1093/cercor/4.1.78 [DOI] [PubMed] [Google Scholar]
  19. Bourgeron T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16 551–563. 10.1038/nrn3992 [DOI] [PubMed] [Google Scholar]
  20. Bulik-Sullivan B K., Loh P., Finucane H. K., Ripke S., Yang J., Patterson N., et al. (2015). LD Score regression distinguishes confounding polygenicity in genome-wide association studies. Nat. Genet. 47 291–295. 10.1038/ng.3211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Buxbaum J., Silverman J., Smith C., Greenberg D., Kilifarski M., Reichert J., et al. (2002). Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7 311–316. 10.1038/sj.mp.4001011 [DOI] [PubMed] [Google Scholar]
  22. Cadigan K. (2008). Wnt/beta-catenin signaling: Turning the switch. Dev. Cell 14 322–323. 10.1016/j.devcel.2008.02.006 [DOI] [PubMed] [Google Scholar]
  23. Cafiero R., Brauer J., Anwander A., Friederici A. (2019). The concurrence of cortical surface area expansion and white matter myelination in human brain development. Cereb. Cortex 29 827–837. 10.1093/cercor/bhy277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Campbell D., Sutcliffe J., Ebert P., Militerni R., Bravaccio C., Trillo S., et al. (2006). A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. U. S. A. 103 16834–16839. 10.1073/pnas.0605296103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Carter C., Bearden C., Bullmore E., Geschwind D., Glahn D., Gur R., et al. (2017). Enhancing the informativeness and replicability of imaging genomics studies. Biol. Psychiatry 82 157–164. 10.1016/j.biopsych.2016.08.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cauvet É., Van’t Westeinde A., Toro R., Kuja-Halkola R., Neufeld J., Mevel K., et al. (2019). Sex differences along the autism continuum: A twin study of brain structure. Cereb. Cortex 29 1342–1350. 10.1093/cercor/bhy303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chen C., Van Horn J. (2017). Developmental neurogenetics and multimodal neuroimaging of sex differences in autism. Brain Imaging Behav. 11 38–61. 10.1007/s11682-015-9504-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Chen J., Lu Y., Xu J., Huang Y., Cheng H., Hu G., et al. (2004). Identification and characterization of NBEAL1, a novel human neurobeachin-like 1 protein gene from fetal brain, which is up regulated in glioma. Brain Res. Mol. Brain Res. 125 147–155. 10.1016/j.molbrainres.2004.02.022 [DOI] [PubMed] [Google Scholar]
  29. Chen J., Peñagarikano O., Belgard T., Swarup V., Geschwind D. (2015). The emerging picture of autism spectrum disorder: Genetics and pathology. Annu. Rev. Pathol. 10 111–144. 10.1146/annurev-pathol-012414-040405 [DOI] [PubMed] [Google Scholar]
  30. Chen J., Tan J., Greenshaw A., Sawalha J., Liu Y., Zhang X., et al. (2020). CACNB2 rs11013860 polymorphism correlates of prefrontal cortex thickness in bipolar patients with first-episode mania. J. Affect. Disord. 268 82–87. 10.1016/j.jad.2020.02.007 [DOI] [PubMed] [Google Scholar]
  31. Chen S., Mantei N., Dong L., Schachner M. (1999). Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1. J. Neurobiol. 38 428–439. [DOI] [PubMed] [Google Scholar]
  32. Chenn A., Walsh C. (2002). Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297 365–369. 10.1126/science.1074192 [DOI] [PubMed] [Google Scholar]
  33. Colantuoni C., Lipska B., Ye T., Hyde T., Tao R., Leek J., et al. (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478 519–523. 10.1038/nature10524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Collins S., Mikhaleva A., Vrcelj K., Vancollie V., Wagner C., Demeure N., et al. (2019). Large-scale neuroanatomical study uncovers 198 gene associations in mouse brain morphogenesis. Nat. Commun. 10:3465. 10.1038/s41467-019-11431-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Constantino J., Davis S., Todd R., Schindler M., Gross M., Brophy S., et al. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. J. Autism Dev. Disord. 33 427–433. 10.1023/a:1025014929212 [DOI] [PubMed] [Google Scholar]
  36. Corradi A., Fadda M., Piton A., Patry L., Marte A., Rossi P., et al. (2014). SYN2 is an autism predisposing gene: Loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth. Hum. Mol. Genet. 23 90–103. 10.1093/hmg/ddt401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cotney J., Muhle R., Sanders S., Liu L., Willsey A., Niu W., et al. (2015). The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat. Commun. 6:6404. 10.1038/ncomms7404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Courchesne E., Campbell K., Solso S. (2011a). Brain growth across the life span in autism: Age-specific changes in anatomical pathology. Brain Res. 1380 138–145. 10.1016/j.brainres.2010.09.101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Courchesne E., Mouton P., Calhoun M., Semendeferi K., Ahrens-Barbeau C., Hallet M., et al. (2011b). Neuron number and size in prefrontal cortex of children with autism. JAMA 306 2001–2010. 10.1001/jama.2011.1638 [DOI] [PubMed] [Google Scholar]
  40. Courchesne E., Pierce K., Schumann C., Redcay E., Buckwalter J., Kennedy D., et al. (2007). Mapping early brain development in autism. Neuron 56 399–413. 10.1016/j.neuron.2007.10.016 [DOI] [PubMed] [Google Scholar]
  41. Dawn Teare M., Barrett J. (2005). Genetic linkage studies. Lancet 366 1036–1044. 10.1016/S0140-6736(05)67382-5 [DOI] [PubMed] [Google Scholar]
  42. de la Torre-Ubieta L., Won H., Stein J., Geschwind D. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22 345–361. 10.1038/nm.4071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. De Rubeis S., He X., Goldberg A., Poultney C., Samocha K., Cicek A., et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515 209–215. 10.1038/nature13772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. De Zeeuw C., Lisberger S., Raymond J. (2021). Diversity and dynamism in the cerebellum. Nat. Neurosci. 24 160–167. 10.1038/s41593-020-00754-9 [DOI] [PubMed] [Google Scholar]
  45. DiBacco M., Pop A., Salomons G., Hanson E., Roullet J., Gibson K., et al. (2020). Novel ALDH5A1 variants and genotype: Phenotype correlation in SSADH deficiency. Neurology 95 e2675–e2682. 10.1212/WNL.0000000000010730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. DiGiacomo V., Meruelo D. (2016). Looking into laminin receptor: Critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein. Biol. Rev. Camb. Philos. Soc. 91 288–310. 10.1111/brv.12170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. DiMario F. (2004). Brain abnormalities in tuberous sclerosis complex. J. Child Neurol. 19 650–657. 10.1177/08830738040190090401 [DOI] [PubMed] [Google Scholar]
  48. Douet V., Chang L., Cloak C., Ernst T. (2014). Genetic influences on brain developmental trajectories on neuroimaging studies: From infancy to young adulthood. Brain Imaging Behav. 8 234–250. 10.1007/s11682-013-9260-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Duarte R., Bachtel N., Côtel M., Lee S., Selvackadunco S., Watson I., et al. (2019). The psychiatric risk gene NT5C2 regulates adenosine monophosphate-activated protein kinase signaling and protein translation in human neural progenitor cells. Biol. Psychiatry 86 120–130. 10.1016/j.biopsych.2019.03.977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ducharme S., Albaugh M., Nguyen T., Hudziak J., Mateos-Pérez J., Labbe A., et al. (2015). Trajectories of cortical surface area and cortical volume maturation in normal brain development. Data Brief 5 929–938. 10.1016/j.dib.2015.10.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ecker C. (2017). The neuroanatomy of autism spectrum disorder: An overview of structural neuroimaging findings and their translatability to the clinical setting. Autism 21 18–28. 10.1177/1362361315627136 [DOI] [PubMed] [Google Scholar]
  52. Ecker C., Bookheimer S., Murphy D. (2015). Neuroimaging in autism spectrum disorder: Brain structure and function across the lifespan. Lancet Neurol. 14 1121–1134. 10.1016/S1474-4422(15)00050-2 [DOI] [PubMed] [Google Scholar]
  53. Ecker C., Ginestet C., Feng Y., Johnston P., Lombardo M., Lai M., et al. (2013). Brain surface anatomy in adults with autism: The relationship between surface area, cortical thickness, and autistic symptoms. JAMA Psychiatry 70 59–70. 10.1001/jamapsychiatry.2013.265 [DOI] [PubMed] [Google Scholar]
  54. Ecker C., Pretzsch C., Bletsch A., Mann C., Schaefer T., Ambrosino S., et al. (2022). Interindividual differences in cortical thickness and their genomic underpinnings in autism spectrum disorder. Am. J. Psychiatry 179 242–254. 10.1176/appi.ajp.2021.20050630 [DOI] [PubMed] [Google Scholar]
  55. Ecker C., Shahidiani A., Feng Y., Daly E., Murphy C., D’Almeida V., et al. (2014). The effect of age, diagnosis, and their interaction on vertex-based measures of cortical thickness and surface area in autism spectrum disorder. J. Neural Transm. 121 1157–1170. 10.1007/s00702-014-1207-1 [DOI] [PubMed] [Google Scholar]
  56. Ellegood J., Anagnostou E., Babineau B., Crawley J., Lin L., Genestine M., et al. (2015). Clustering autism: Using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Mol. Psychiatry 20 118–125. 10.1038/mp.2014.98 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Fatemi S., Aldinger K., Ashwood P., Bauman M., Blaha C., Blatt G., et al. (2012). Consensus paper: Pathological role of the cerebellum in autism. Cerebellum 11 777–807. 10.1007/s12311-012-0355-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Fawzi A., Achuthan A., Belaton B. (2021). Brain image segmentation in recent years: A Narrative Review. Brain Sci. 11:1055. 10.3390/brainsci11081055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Fetit R., Hillary R., Price D., Lawrie S. (2021). The neuropathology of autism: A systematic review of post-mortem studies of autism and related disorders. Neurosci. Biobehav. Rev. 129 35–62. 10.1016/j.neubiorev.2021.07.014 [DOI] [PubMed] [Google Scholar]
  60. Fischl B., Sereno M., Tootell R., Dale A. (1999). High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 8 272–284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Fjell A., Grydeland H., Krogsrud S., Amlien I., Rohani D., Ferschmann L., et al. (2015). Development and aging of cortical thickness correspond to genetic organization patterns. Proc. Natl. Acad. Sci. U. S. A. 112 15462–15467. 10.1073/pnas.1508831112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Floris D., Peng H., Warrier V., Lombardo M., Pretzsch C., Moreau C., et al. (2023). The link between autism and sex-related neuroanatomy, and associated cognition and gene expression. Am. J. Psychiatry 180 50–64. 10.1176/appi.ajp.20220194 [DOI] [PubMed] [Google Scholar]
  63. Frazier T., Embacher R., Tilot A., Koenig K., Mester J., Eng C. (2015). Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol. Psychiatry 20 1132–1138. 10.1038/mp.2014.125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Fu C., Cawthon B., Clinkscales W., Bruce A., Winzenburger P., Ess K. (2012). Gabaergic interneuron development and function is modulated by the Tsc1 gene. Cereb. Cortex 22 2111–2119. 10.1093/cercor/bhr300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Gandal M., Zhang P., Hadjimichael E., Walker R., Chen C., Liu S., et al. (2018). Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362:eaat8127. 10.1126/science.aat8127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Geschwind D., Sowinski J., Lord C., Iversen P., Shestack J., Jones P., et al. (2001). The autism genetic resource exchange: A resource for the study of autism and related neuropsychiatric conditions. Am. J. Hum. Genet. 69 463–466. 10.1086/321292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Gilmore J., Schmitt J., Knickmeyer R., Smith J., Lin W., Styner M., et al. (2010). Genetic and environmental contributions to neonatal brain structure: A twin study. Hum. Brain Mapp. 31 1174–1182. 10.1002/hbm.20926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Godel M., Andrews D., Amaral D., Ozonoff S., Young G., Lee J., et al. (2021). Altered gray-white matter boundary contrast in toddlers at risk for autism relates to later diagnosis of autism spectrum disorder. Front. Neurosci. 15:669194. 10.3389/fnins.2021.669194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Grasby K., Jahanshad N., Painter J., Colodro-Conde L., Bralten J., Hibar D., et al. (2020). The genetic architecture of the human cerebral cortex. Science 367:eaay6690. 10.1126/science.aay6690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Grove J., Ripke S., Als T., Mattheisen M., Walters R., Won H., et al. (2019). Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51 431–444. 10.1038/s41588-019-0344-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Hampson D., Blatt G. (2015). Autism spectrum disorders and neuropathology of the cerebellum. Front. Neurosci. 9:420. 10.3389/fnins.2015.00420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., et al. (2006). Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 32 180–194. 10.1016/j.neuroimage.2006.02.051 [DOI] [PubMed] [Google Scholar]
  73. Hansen D., Rubenstein J., Kriegstein A. (2011). Deriving excitatory neurons of the neocortex from pluripotent stem cells. Neuron 70 645–660. 10.1016/j.neuron.2011.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Hashem S., Nisar S., Bhat A., Yadav S., Azeem M., Bagga P., et al. (2020). Genetics of structural and functional brain changes in autism spectrum disorder. Transl. Psychiatry 10:229. 10.1038/s41398-020-00921-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Haynes R., Borenstein N., Desilva T., Folkerth R., Liu L., Volpe J., et al. (2005). Axonal development in the cerebral white matter of the human fetus and infant. J. Comp. Neurol. 484 156–167. 10.1002/cne.20453 [DOI] [PubMed] [Google Scholar]
  76. Hazlett H., Poe M., Gerig G., Styner M., Chappell C., Smith R., et al. (2011). Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch. Gen. Psychiatry 68 467–476. 10.1001/archgenpsychiatry.2011.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Hedrick A., Lee Y., Wallace G., Greenstein D., Clasen L., Giedd J., et al. (2012). Autism risk gene MET variation and cortical thickness in typically developing children and adolescents. Autism Res. 5 434–439. 10.1002/aur.1256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Hegarty J., Pegoraro L., Lazzeroni L., Raman M., Hallmayer J., Monterrey J., et al. (2020). Genetic and environmental influences on structural brain measures in twins with autism spectrum disorder. Mol. Psychiatry 25 2556–2566. 10.1038/s41380-018-0330-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Hofer E., Roshchupkin G., Adams H., Knol M., Lin H., Li S., et al. (2020). Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults. Nat. Commun. 11:4796. 10.1038/s41467-020-18367-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hogstrom L., Westlye L., Walhovd K., Fjell A. (2013). The structure of the cerebral cortex across adult life: Age-related patterns of surface area, thickness, and gyrification. Cereb. Cortex 23 2521–2530. 10.1093/cercor/bhs231 [DOI] [PubMed] [Google Scholar]
  81. Horn Z., Behesti H., Hatten M. E. (2018). N-cadherin provides a cis and trans ligand for astrotactin that functions in glial-guided neuronal migration. Proc. Natl. Acad. Sci. U. S. A. 115 10556–10563. 10.1073/pnas.1811100115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Huang H., Zhang J., Wakana S., Zhang W., Ren T., Richards L., et al. (2006). White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage 33 27–38. 10.1016/j.neuroimage.2006.06.009 [DOI] [PubMed] [Google Scholar]
  83. Hu-Lince D., Craig D., Huentelman M., Stephan D. (2005). The Autism Genome Project: Goals and strategies. Am. J. Pharm. 5 233–246. 10.2165/00129785-200505040-00004 [DOI] [PubMed] [Google Scholar]
  84. Hutsler J., Love T., Zhang H. (2007). Histological and magnetic resonance imaging assessment of cortical layering and thickness in autism spectrum disorders. Biol. Psychiatry 61 449–457. 10.1016/j.biopsych.2006.01.015 [DOI] [PubMed] [Google Scholar]
  85. Huttenlocher P. (1979). Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 163 195–205. 10.1016/0006-8993(79)90349-4 [DOI] [PubMed] [Google Scholar]
  86. Huttner W., Kosodo Y. (2005). Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system. Curr. Opin. Cell Biol. 17 648–657. 10.1016/j.ceb.2005.10.005 [DOI] [PubMed] [Google Scholar]
  87. Im K., Lee J., Lyttelton O., Kim S., Evans A., Kim S. (2008). Brain size and cortical structure in the adult human brain. Cereb. Cortex 18 2181–2191. 10.1093/cercor/bhm244 [DOI] [PubMed] [Google Scholar]
  88. Itoh Y. (2016). A balancing Akt: How to fine-tune neuronal migration speed. Neurogenesis 3:e1256854. 10.1080/23262133.2016.1256854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Jamain S., Betancur C., Quach H., Philippe A., Fellous M., Giros B., et al. (2002). Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry 7 302–310. 10.1038/sj.mp.4000979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Jamain S., Quach H., Betancur C., Råstam M., Colineaux C., Gillberg I., et al. (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 27–29. 10.1038/ng1136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Jansen A., Mous S., White T., Posthuma D., Polderman T. (2015). What twin studies tell us about the heritability of brain development, morphology, and function: A review. Neuropsychol. Rev. 25 27–46. 10.1007/s11065-015-9278-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Jayakumar A., Tong X., Curtis K., Ruiz-Cordero R., Shamaladevi N., Abuzamel M., et al. (2014). Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: In vitro and in vivo studies. J. Neurochem. 131 333–347. 10.1111/jnc.12810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Jenett A. (2020). “Registered, standardized, and interactive: A review of online resources for zebrafish neuroanatomy,” in Behavioral and Neural Genetics of Zebrafish, ed. Gerlai R. (Amsterdam: Elsevier; ), 563–580. [Google Scholar]
  94. Jha S., Xia K., Schmitt J., Ahn M., Girault J., Murphy V., et al. (2018). Genetic influences on neonatal cortical thickness and surface area. Hum. Brain Mapp. 39 4998–5013. 10.1002/hbm.24340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Johnson M., Kawasawa Y., Mason C., Krsnik Z., Coppola G., Bogdanović D., et al. (2009). Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62 494–509. 10.1016/j.neuron.2009.03.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Jones E. G. (1984). “Laminar distribution of cortical efferent cells,” in Cerebral cortex: Cellular components of the cerebral cortex, eds Peters A., Jones E. G. (New York, NY: Plenum Press; ), 521–553. [Google Scholar]
  97. Joshi Y., Giannopoulos P., Chu J., Sperow M., Kirby L., Abood M., et al. (2014). Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer’s disease. Hum. Mol. Genet. 23 6894–6902. 10.1093/hmg/ddu412 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  98. Kates W., Ikuta I., Burnette C. (2009). Gyrification patterns in monozygotic twin pairs varying in discordance for autism. Autism Res. 2 267–278. 10.1002/aur.98 [DOI] [PubMed] [Google Scholar]
  99. Katoh M., Katoh M. (2017). Molecular genetics and targeted therapy of WNT-related human diseases (Review). Int. J. Mol. Med. 40 587–606. 10.3892/ijmm.2017.3071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Keidar L., Gerlitz G., Kshirsagar A., Tsoory M., Olender T., Wang X., et al. (2019). Interplay of LIS1 and MeCP2: Interactions and implications with the neurodevelopmental disorders lissencephaly and rett syndrome. Front. Cell Neurosci. 13:370. 10.3389/fncel.2019.00370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Khundrakpam B., Lewis J., Kostopoulos P., Carbonell F., Evans A. (2017). Cortical thickness abnormalities in autism spectrum disorders through late childhood, adolescence, and adulthood: A large-scale mri study. Cereb. Cortex 27 1721–1731. 10.1093/cercor/bhx038 [DOI] [PubMed] [Google Scholar]
  102. Khundrakpam B., Vainik U., Gong J., Al-Sharif N., Bhutani N., Kiar G., et al. (2020). Neural correlates of polygenic risk score for autism spectrum disorders in general population. Brain Commun. 2:fcaa092. 10.1093/braincomms/fcaa092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Klein D., Rotarska-Jagiela A., Genc E., Sritharan S., Mohr H., Roux F., et al. (2014). Adolescent brain maturation and cortical folding: Evidence for reductions in gyrification. PLoS One 9:e84914. 10.1371/journal.pone.0084914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Knopf A. (2020). Autism prevalence increases from 1 in 60 to 1 in 54: CDC. Brown Univ. Child Adoles. Behav. Lett. 36:4. [Google Scholar]
  105. Kohli J., Kinnear M., Fong C., Fishman I., Carper R., Müller R. (2019a). Local cortical gyrification is increased in children with autism spectrum disorders, but decreases rapidly in adolescents. Cereb. Cortex 29 2412–2423. 10.1093/cercor/bhy111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Kohli J., Kinnear M., Martindale I., Carper R., Müller R. (2019b). Regionally decreased gyrification in middle-aged adults with autism spectrum disorders. Neurology 93 e1900–e1905. 10.1212/WNL.0000000000008478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Kriegstein A., Noctor S. (2004). Patterns of neuronal migration in the embryonic cortex. Trends Neurosci. 27 392–399. 10.1016/j.tins.2004.05.001 [DOI] [PubMed] [Google Scholar]
  108. Krmpotić-Nemanić J., Kostović I., Nemanić D. (1984). Prenatal and perinatal development of radial cell columns in the human auditory cortex. Acta Otolaryngol. 97 489–495. 10.3109/00016488409132926 [DOI] [PubMed] [Google Scholar]
  109. Krumm N., O’Roak B., Shendure J., Eichler E. E. (2014). A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 37 95–105. 10.1016/j.tins.2013.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Kurochkin I., Khrameeva E., Tkachev A., Stepanova V., Vanyushkina A., Stekolshchikova E., et al. (2019). Metabolome signature of autism in the human prefrontal cortex. Commun. Biol. 2:234. 10.1038/s42003-019-0485-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Kushki A., Anagnostou E., Hammill C., Duez P., Brian J., Iaboni A., et al. (2019). Examining overlap and homogeneity in ASD, ADHD, and OCD: A data-driven, diagnosis-agnostic approach. Transl. Psychiatry 9:318. 10.1038/s41398-019-0631-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Lai M., Lombardo M., Auyeung B., Chakrabarti B., Baron-Cohen S. (2015). Sex/gender differences and autism: Setting the scene for future research. J. Am. Acad. Child Adolesc. Psychiatry 54 11–24. 10.1016/j.jaac.2014.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Lange N., Travers B., Bigler E. D., Prigge M., Froehlich A., Nielsen J., et al. (2015). Longitudinal volumetric brain changes in autism spectrum disorder ages 6-35 years. Autism Res. 8 82–93. 10.1002/aur.1427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Lasalle J. (2013). Autism genes keep turning up chromatin. OA Autism 1:14. 10.13172/2052-7810-1-2-610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Lee P., Feng Y., Smoller J. (2021). Pleiotropy and cross-disorder genetics among psychiatric disorders. Biol. Psychiatry 89 20–31. 10.1016/j.biopsych.2020.09.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Lewis J., Elman J. (2008). Growth-related neural reorganization and the autism phenotype: A test of the hypothesis that altered brain growth leads to altered connectivity. Dev. Sci. 11 135–155. 10.1111/j.1467-7687.2007.00634.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Li L., Zuo Y., Chen Y. (2021). Relationship between local gyrification index and age, intelligence quotient, symptom severity with autism spectrum disorder: A large-scale MRI study. J. Clin. Neurosci. 91 193–199. 10.1016/j.jocn.2021.07.003 [DOI] [PubMed] [Google Scholar]
  118. Libero L., Schaer M., Li D., Amaral D., Nordahl C. W. A. (2019). Longitudinal study of local gyrification index in young boys with autism spectrum disorder. Cereb. Cortex 29 2575–2587. 10.1093/cercor/bhy126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Lyall A., Shi F., Geng X., Woolson S., Li G., Wang L., et al. (2015). Dynamic development of regional cortical thickness and surface area in early childhood. Cereb. Cortex 25 2204–2212. 10.1093/cercor/bhu027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. MacDonald D., Kabani N., Avis D., Evans A. (2000). Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 12 340–356. 10.1006/nimg.1999.0534 [DOI] [PubMed] [Google Scholar]
  121. Magnotta V., Andreasen N., Schultz S., Harris G., Cizadlo T., Heckel D., et al. (1999). Quantitative in vivo measurement of gyrification in the human brain: Changes associated with aging. Cereb. Cortex 9 151–160. 10.1093/cercor/9.2.151 [DOI] [PubMed] [Google Scholar]
  122. Mann C., Bletsch A., Andrews D., Daly E., Murphy C., Murphy D., et al. (2018). The effect of age on vertex-based measures of the grey-white matter tissue contrast in autism spectrum disorder. Mol. Autism 9:49. 10.1186/s13229-018-0232-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Marek S., Tervo-Clemmens B., Calabro F., Montez D., Kay B., Hatoum A., et al. (2022). Reproducible brain-wide association studies require thousands of individuals. Nature 603 654–660. 10.1038/s41586-022-04492-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. McConnell S., Ghosh A., Shatz C. (1994). Subplate pioneers and the formation of descending connections from cerebral cortex. J. Neurosci. 14 1892–1907. 10.1523/JNEUROSCI.14-04-01892.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Mensen V., Wierenga L., van Dijk S., Rijks Y., Oranje B., Mandl R., et al. (2016). Development of cortical thickness and surface area in autism spectrum disorder. Neuroimage Clin. 13 215–222. 10.1016/j.nicl.2016.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H., Pappu R., Campana D., et al. (1999). An essential role for BLNK in human B cell development. Science 286 1954–1957. 10.1126/science.286.5446.1954 [DOI] [PubMed] [Google Scholar]
  127. Murphy D., Spooren W. (2012). EU-AIMS: A boost to autism research. Nat. Rev. Drug Discov. 11 815–816. 10.1038/nrd3881 [DOI] [PubMed] [Google Scholar]
  128. Naidich T., Grant J., Altman N., Zimmerman R., Birchansky S., Braffman B., et al. (1994). The developing cerebral surface. Preliminary report on the patterns of sulcal and gyral maturation–anatomy, ultrasound, and magnetic resonance imaging. Neuroimaging Clin. N. Am. 4 201–240. [PubMed] [Google Scholar]
  129. Nishimune A., Isaac J., Molnar E., Noel J., Nash S., Tagaya M., et al. (1998). NSF binding to GluR2 regulates synaptic transmission. Neuron 21 87–97. 10.1016/s0896-6273(00)80517-6 [DOI] [PubMed] [Google Scholar]
  130. Nishiyama M., Oshikawa K., Tsukada Y., Nakagawa T., Iemura S., Natsume T., et al. (2009). CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat. Cell Biol. 11 172–182. 10.1038/ncb1831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Noctor S., Flint A., Weissman T., Dammerman R., Kriegstein A. (2001). Neurons derived from radial glial cells establish radial units in neocortex. Nature 409 714–720. 10.1038/35055553 [DOI] [PubMed] [Google Scholar]
  132. Ollier W., Sprosen T., Peakman T. (2005). UK Biobank: From concept to reality. Pharmacogenomics 6 639–646. 10.2217/14622416.6.6.639 [DOI] [PubMed] [Google Scholar]
  133. O’Roak B., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B., et al. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485 246–250. 10.1038/nature10989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Pacheco J., Beevers C., Benavides C., McGeary J., Stice E., Schnyer D. (2009). Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J. Neurosci. 29 6229–6233. 10.1523/JNEUROSCI.0896-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Panizzon M., Fennema-Notestine C., Eyler L., Jernigan T., Prom-Wormley E., Neale M., et al. (2009). Distinct genetic influences on cortical surface area and cortical thickness. Cereb. Cortex 19 2728–2735. 10.1093/cercor/bhp026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Panizzon M., Fennema-Notestine C., Kubarych T., Chen C., Eyler L., Fischl B., et al. (2012). Genetic and environmental influences of white and gray matter signal contrast: A new phenotype for imaging genetics? Neuroimage 60 1686–1695. 10.1016/j.neuroimage.2012.01.122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Papiol S., Mitjans M., Assogna F., Piras F., Hammer C., Caltagirone C., et al. (2014). Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample. Transl. Psychiatry 4:e362. 10.1038/tp.2013.126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Parikshak N., Luo R., Zhang A., Won H., Lowe J., Chandran V., et al. (2013). Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155 1008–1021. 10.1016/j.cell.2013.10.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Parikshak N., Swarup V., Belgard T., Irimia M., Ramaswami G., Gandal M., et al. (2016). Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature 540 423–427. 10.1038/nature20612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Penisson M., Ladewig J., Belvindrah R., Francis F. (2019). Genes and mechanisms involved in the generation and amplification of basal radial glial cells. Front. Cell Neurosci. 13:381. 10.3389/fncel.2019.00381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Petanjek Z., Judaš M., Šimic G., Rasin M., Uylings H., Rakic P., et al. (2011). Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 108 13281–13286. 10.1073/pnas.1105108108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Pino E., Amamoto R., Zheng L., Cacquevel M., Sarria J., Knott G., et al. (2014). FOXO3 determines the accumulation of α-synuclein and controls the fate of dopaminergic neurons in the substantia nigra. Hum. Mol. Genet. 23 1435–1452. 10.1093/hmg/ddt530 [DOI] [PubMed] [Google Scholar]
  143. Pizzagalli F., Auzias G., Yang Q., Mathias S., Faskowitz J., Boyd J., et al. (2020). The reliability and heritability of cortical folds and their genetic correlations across hemispheres. Commun. Biol. 3:510. 10.1038/s42003-020-01163-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Plump A., Erskine L., Sabatier C., Brose K., Epstein C., Goodman C., et al. (2002). Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system. Neuron 33 219–232. 10.1016/s0896-6273(01)00586-4 [DOI] [PubMed] [Google Scholar]
  145. Polioudakis D., de la Torre-Ubieta L., Langerman J., Elkins A., Shi X., Stein J., et al. (2019). A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation. Neuron 103 785–801.e8. 10.1016/j.neuron.2019.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Pook C., Ahrens J., Clagett-Dame M. (2020). Expression pattern of Nav2 in the murine CNS with development. Gene Exp. Patterns 35:119099. 10.1016/j.gep.2020.119099 [DOI] [PubMed] [Google Scholar]
  147. Pretzsch C., Schäfer T., Lombardo M., Warrier V., Mann C., Bletsch A., et al. (2022). Neurobiological correlates of change in adaptive behavior in autism. Am. J. Psychiatry 179 336–349. 10.1176/appi.ajp.21070711 [DOI] [PubMed] [Google Scholar]
  148. Pretzsch C. M., Ecker C. (2022). “The Neuroanatomy of Autism,” in The Neuroscience of Autism, ed. Kana R. (Amsterdam: Elsevier; ), 296. [Google Scholar]
  149. Pretzsch C. M., Findon J. L., Murphy D. G. (2019). “Autism Spectrum Disorders in Adults,” in The Oxford Handbook of Adult Cognitive Disorders, eds Alosco M. L., Stern R. A. (Oxford: Oxford Univerity Press; ), 359. [Google Scholar]
  150. Purcell A., Jeon O., Zimmerman A., Blue M., Pevsner J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 1618–1628. 10.1212/wnl.57.9.1618 [DOI] [PubMed] [Google Scholar]
  151. Qureshi A., Mueller S., Snyder A., Mukherjee P., Berman J., Roberts T., et al. (2014). Opposing brain differences in 16p11.2 deletion and duplication carriers. J. Neurosci. 34 11199–11211. 10.1523/JNEUROSCI.1366-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Rae J., Newburger P., Dinauer M., Noack D., Hopkins P., Kuruto R., et al. (1998). X-Linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am. J. Hum. Genet. 62 1320–1331. 10.1086/301874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Rakic P. (1972). Mode of cell migration to the superficial layers of fetal monkey neocortex. J. Comp. Neurol. 145 61–83. 10.1002/cne.901450105 [DOI] [PubMed] [Google Scholar]
  154. Rakic P. (1978). Neuronal migration and contact guidance in the primate telencephalon. Postgrad. Med. J. 54 25–40. [PubMed] [Google Scholar]
  155. Ranzenberger L., Snyder T. (2023). Diffusion tensor imaging. Treasure Island, FL: StatPearls Publishing. [PubMed] [Google Scholar]
  156. Raznahan A., Shaw P., Lalonde F., Stockman M., Wallace G., Greenstein D., et al. (2011b). How does your cortex grow? J. Neurosci. 31 7174–7177. 10.1523/JNEUROSCI.0054-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Raznahan A., Greenstein D., Lee Y., Long R., Clasen L., Gochman P., et al. (2011a). Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage 57 1517–1523. 10.1016/j.neuroimage.2011.05.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Raznahan A., Toro R., Proitsi P., Powell J., Paus T., Bolton P., et al. (2009). A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. J. Neurodev. Disord. 1 215–223. 10.1007/s11689-009-9012-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Retzius G. (1891). Ueber den Bau der Oberflächenschicht der Grosshirnrinde beim Menschen und bei den Säugethieren. Stockholm: Aftonbladets Aktiebolags tryckeri. [Google Scholar]
  160. Rimol L., Panizzon M., Fennema-Notestine C., Eyler L., Fischl B., Franz C., et al. (2010). Cortical thickness is influenced by regionally specific genetic factors. Biol. Psychiatry 67 493–499. 10.1016/j.biopsych.2009.09.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Roffé M., Hajj G., Azevedo H., Alves V., Castilho B. A. (2013). IMPACT is a developmentally regulated protein in neurons that opposes the eukaryotic initiation factor 2α kinase GCN2 in the modulation of neurite outgrowth. J. Biol. Chem. 288 10860–10869. 10.1074/jbc.M113.461970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Ronan L., Voets N., Rua C., Alexander-Bloch A., Hough M., Mackay C., et al. (2014). Differential tangential expansion as a mechanism for cortical gyrification. Cereb. Cortex 24 2219–2228. 10.1093/cercor/bht082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Ross P., Zhang W., Mok R., Zaslavsky K., Deneault E., D’Abate L., et al. (2020). Synaptic dysfunction in human neurons with autism-associated deletions in PTCHD1-AS. Biol. Psychiatry. 87 139–149. 10.1016/j.biopsych.2019.07.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Ruhl D., Bomba-Warczak E., Watson E., Bradberry M., Peterson T., Basu T., et al. (2019). Synaptotagmin 17 controls neurite outgrowth and synaptic physiology via distinct cellular pathways. Nat. Commun. 10:3532. 10.1038/s41467-019-11459-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Sahin M., Sur M. (2015). Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science 350:10.1126/science.aab3897aab3897. 10.1126/science.aab3897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Saito Y., Suga M., Tochigi M., Abe O., Yahata N., Kawakubo Y., et al. (2014). Neural correlate of autistic-like traits and a common allele in the oxytocin receptor gene. Soc. Cogn. Affect. Neurosci. 9 1443–1450. 10.1093/scan/nst136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Salat D., Lee S., van der Kouwe A., Greve D., Fischl B., Rosas H. (2009). Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 48 21–28. 10.1016/j.neuroimage.2009.06.074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Savage J., Jansen P., Stringer S., Watanabe K., Bryois J., de Leeuw C., et al. (2018). Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat. Genet. 50 912–919. 10.1038/s41588-018-0152-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Schaer M., Cuadra M., Schmansky N., Fischl B., Thiran J., Eliez S. (2012). How to measure cortical folding from MR images: A step-by-step tutorial to compute local gyrification index. J. Vis. Exp. 59:e3417. 10.3791/3417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Schmitt J., Raznahan A., Liu S., Neale M. (2021). The heritability of cortical folding: Evidence from the human connectome project. Cereb. Cortex 31 702–715. 10.1093/cercor/bhaa254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Schumann C., Nordahl C. (2011). Bridging the gap between MRI and postmortem research in autism. Brain Res. 1380 175–186. 10.1016/j.brainres.2010.09.061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Seldon H. (2005). Does brain white matter growth expand the cortex like a balloon? Hypothesis and consequences. Laterality 10 81–95. 10.1080/13576500342000310 [DOI] [PubMed] [Google Scholar]
  173. Shelton A., Cornish K., Kolbe S., Clough M., Slater H., Li X., et al. (2016). Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. Transl. Psychiatry 6:e984. 10.1038/tp.2016.250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Shen M., Nordahl C., Li D., Lee A., Angkustsiri K., Emerson R., et al. (2018). Extra-axial cerebrospinal fluid in high-risk and normal-risk children with autism aged 2-4 years: A case-control study. Lancet Psychiatry 5 895–904. 10.1016/S2215-0366(18)30294-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Shin J., French L., Xu T., Leonard G., Perron M., Pike G., et al. (2018). Cell-specific gene-expression profiles and cortical thickness in the human brain. Cereb. Cortex 28 3267–3277. 10.1093/cercor/bhx197 [DOI] [PubMed] [Google Scholar]
  176. Solozobova V., Wyvekens N., Pruszak J. (2012). Lessons from the embryonic neural stem cell niche for neural lineage differentiation of pluripotent stem cells. Stem Cell Rev. Rep. 8 813–829. 10.1007/s12015-012-9381-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Sowell E., Peterson B., Thompson P., Welcome S., Henkenius A., Toga A. (2003). Mapping cortical change across the human life span. Nat. Neurosci. 6 309–315. 10.1038/nn1008 [DOI] [PubMed] [Google Scholar]
  178. Sticco M., Peña Palomino P., Lukacsovich D., Thompson B., Földy C., Ressl S., et al. (2021). C1QL3 promotes cell-cell adhesion by mediating complex formation between ADGRB3/BAI3 and neuronal pentraxins. FASEB J. 35:e21194. 10.1096/fj.202000351RR [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Storsve A., Fjell A., Tamnes C., Westlye L., Overbye K., Aasland H., et al. (2014). Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: Regions of accelerating and decelerating change. J. Neurosci. 34 8488–8498. 10.1523/JNEUROSCI.0391-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Sung P., Boulos N., Tilby M., Andrews W., Newbold R., Tweddle D., et al. (2013). Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation. Cancer Lett. 328 168–175. 10.1016/j.canlet.2012.08.015 [DOI] [PubMed] [Google Scholar]
  181. Tang G., Gudsnuk K., Kuo S., Cotrina M., Rosoklija G., Sosunov A., et al. (2014). Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83 1131–1143. 10.1016/j.neuron.2014.07.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. The Schizophrenia Psychiatric Genome-Wide Association Study [GWAS] Consortium (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43 969–976. 10.1038/ng.940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Thompson P., Stein J., Medland S., Hibar D., Vasquez A., Renteria M., et al. (2014). The ENIGMA Consortium: Large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 8 153–182. 10.1007/s11682-013-9269-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Tiberi L., Vanderhaeghen P., van den Ameele J. (2012). Cortical neurogenesis and morphogens: Diversity of cues, sources and functions. Curr. Opin. Cell Biol. 24 269–276. 10.1016/j.ceb.2012.01.010 [DOI] [PubMed] [Google Scholar]
  185. Tordjman S., Gutknecht L., Carlier M., Spitz E., Antoine C., Slama F., et al. (2001). Role of the serotonin transporter gene in the behavioral expression of autism. Mol. Psychiatry 6 434–439. 10.1038/sj.mp.4000873 [DOI] [PubMed] [Google Scholar]
  186. Tordjman S., Somogyi E., Coulon N., Kermarrec S., Cohen D., Bronsard G., et al. (2014). Gene × Environment interactions in autism spectrum disorders: Role of epigenetic mechanisms. Front. Psychiatry 5:53. 10.3389/fpsyt.2014.00053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Toro R., Poline J., Huguet G., Loth E., Frouin V., Banaschewski T., et al. (2015). Genomic architecture of human neuroanatomical diversity. Mol. Psychiatry 20 1011–1016. 10.1038/mp.2014.99 [DOI] [PubMed] [Google Scholar]
  188. Travers B., Adluru N., Ennis C., Tromp P., Destiche D., Doran S., et al. (2012). Diffusion tensor imaging in autism spectrum disorder: A review. Autism Res. 5 289–313. 10.1002/aur.1243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. van der Lee S., Knol M., Chauhan G., Satizabal C., Smith A., Hofer E., et al. (2019). A genome-wide association study identifies genetic loci associated with specific lobar brain volumes. Commun. Biol. 2:285. 10.1038/s42003-019-0537-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. van der Meer D., Frei O., Kaufmann T., Chen C., Thompson W., O’Connell K., et al. (2020). Quantifying the polygenic architecture of the human cerebral cortex: Extensive genetic overlap between cortical thickness and surface area. Cereb. Cortex 30 5597–5603. 10.1093/cercor/bhaa146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. van der Meer D., Kaufmann T., Shadrin A., Makowski C., Frei O., Roelfs D., et al. (2021). The genetic architecture of human cortical folding. Sci. Adv. 7:eabj9446. 10.1126/sciadv.abj9446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. van Diepen M., Eickholt B. (2008). Function of PTEN during the formation and maintenance of neuronal circuits in the brain. Dev. Neurosci. 30 59–64. 10.1159/000109852 [DOI] [PubMed] [Google Scholar]
  193. Van Essen D. (1997). A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature 385 313–318. 10.1038/385313a0 [DOI] [PubMed] [Google Scholar]
  194. Vidal-Pineiro D., Parker N., Shin J., French L., Grydeland H., Jackowski A., et al. (2020). Cellular correlates of cortical thinning throughout the lifespan. Sci. Rep. 10:21803. 10.1038/s41598-020-78471-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Vo T., Carulli D., Ehlert E., Kwok J., Dick G., Mecollari V., et al. (2013). The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain. Mol. Cell Neurosci. 56 186–200. 10.1016/j.mcn.2013.04.009 [DOI] [PubMed] [Google Scholar]
  196. Voineagu I., Wang X., Johnston P., Lowe J., Tian Y., Horvath S., et al. (2011). Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474 380–384. 10.1038/nature10110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Volpe J. (1981). Neurology of the newborn. Major Probl. Clin. Pediatr. 22 1–648. [PubMed] [Google Scholar]
  198. Wallace G., Eisenberg I., Robustelli B., Dankner N., Kenworthy L., Giedd J., et al. (2015). Longitudinal cortical development during adolescence and young adulthood in autism spectrum disorder: Increased cortical thinning but comparable surface area changes. J. Am. Acad. Child Adolesc. Psychiatry 54 464–469. 10.1016/j.jaac.2015.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Wallace G., Eric Schmitt J., Lenroot R., Viding E., Ordaz S., Rosenthal M., et al. (2006). A pediatric twin study of brain morphometry. J. Child Psychol. Psychiatry 47 987–993. 10.1111/j.1469-7610.2006.01676.x [DOI] [PubMed] [Google Scholar]
  200. Wang J., Gong J., Li L., Chen Y., Liu L., Gu H., et al. (2018). Neurexin gene family variants as risk factors for autism spectrum disorder. Autism Res. 11 37–43. 10.1002/aur.1881 [DOI] [PubMed] [Google Scholar]
  201. Wang N., Anderson R., Ashbrook D., Gopalakrishnan V., Park Y., Priebe C., et al. (2020). Variability and heritability of mouse brain structure: Microscopic MRI atlases and connectomes for diverse strains. Neuroimage 222:117274. 10.1016/j.neuroimage.2020.117274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Wassink T., Hazlett H., Epping E., Arndt S., Dager S., Schellenberg G., et al. (2007). Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch. Gen. Psychiatry 64 709–717. 10.1001/archpsyc.64.6.709 [DOI] [PubMed] [Google Scholar]
  203. Wathlet S., Adriaenssens T., Segers I., Verheyen G., Van de Velde H., Coucke W., et al. (2011). Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum. Reprod. 26 1035–1051. 10.1093/humrep/der036 [DOI] [PubMed] [Google Scholar]
  204. Wegiel J., Kuchna I., Nowicki K., Imaki H., Wegiel J., Marchi E., et al. (2010). The neuropathology of autism: Defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 119 755–770. 10.1007/s00401-010-0655-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Wei Q., Li M., Kang Z., Li L., Diao F., Zhang R., et al. (2015). ZNF804A rs1344706 is associated with cortical thickness, surface area, and cortical volume of the unmedicated first episode schizophrenia and healthy controls. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168B 265–273. 10.1002/ajmg.b.32308 [DOI] [PubMed] [Google Scholar]
  206. Weiss L., Escayg A., Kearney J., Trudeau M., MacDonald B., Mori M., et al. (2003). Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry 8 186–194. 10.1038/sj.mp.4001241 [DOI] [PubMed] [Google Scholar]
  207. White T., Su S., Schmidt M., Kao C., Sapiro G. (2010). The development of gyrification in childhood and adolescence. Brain Cogn. 72 36–45. 10.1016/j.bandc.2009.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Winkler A., Kochunov P., Blangero J., Almasy L., Zilles K., Fox P., et al. (2010). Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 53 1135–1146. 10.1016/j.neuroimage.2009.12.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Winkler A., Sabuncu M., Yeo B., Fischl B., Greve D., Kochunov P., et al. (2012). Measuring and comparing brain cortical surface area and other areal quantities. Neuroimage 61 1428–1443. 10.1016/j.neuroimage.2012.03.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Wiśniowiecka-Kowalnik B., Nowakowska B. (2019). Genetics and epigenetics of autism spectrum disorder-current evidence in the field. J. Appl. Genet. 60 37–47. 10.1007/s13353-018-00480-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Woodbury-Smith M., Nicolson R., Zarrei M., Yuen R., Walker S., Howe J., et al. (2017). Variable phenotype expression in a family segregating microdeletions of the NRXN1 and MBD5 autism spectrum disorder susceptibility genes. NPJ Genom. Med. 2:17. 10.1038/s41525-017-0020-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Woodbury-Smith M., Scherer S. (2018). Progress in the genetics of autism spectrum disorder. Dev. Med. Child Neurol. 60 445–451. 10.1111/dmcn.13717 [DOI] [PubMed] [Google Scholar]
  213. Wright I., McGuire P., Poline J., Travere J., Murray R., Frith C., et al. (1995). A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage 2 244–252. 10.1006/nimg.1995.1032 [DOI] [PubMed] [Google Scholar]
  214. Wrobel C., Mutch C., Swaminathan S., Taketo M., Chenn A. (2007). Persistent expression of stabilized beta-catenin delays maturation of radial glial cells into intermediate progenitors. Dev. Biol. 309 285–297. 10.1016/j.ydbio.2007.07.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Xia K., Zhang J., Ahn M., Jha S., Crowley J., Szatkiewicz J., et al. (2017). Genome-wide association analysis identifies common variants influencing infant brain volumes. Transl. Psychiatry 7:e1188. 10.1038/tp.2017.159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Yip J., Soghomonian J., Blatt G. (2009). Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: An in situ hybridization study. Autism Res. 2 50–59. 10.1002/aur.62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Zhang Y., Landback P., Vibranovski M., Long M. (2011). Accelerated recruitment of new brain development genes into the human genome. PLoS Biol. 9:e1001179. 10.1371/journal.pbio.1001179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Zhao B., Zhang J., Ibrahim J., Luo T., Santelli R., Li Y., et al. (2021). Large-scale GWAS reveals genetic architecture of brain white matter microstructure and genetic overlap with cognitive and mental health traits (n = 17,706). Mol. Psychiatry 26 3943–3955. 10.1038/s41380-019-0569-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Zhao W., Zhang Q., Chen X., Li Y., Li X., Du B., et al. (2021). The VNTR of the AS3MT gene is associated with brain activations during a memory span task and their training-induced plasticity. Psychol. Med. 51 1927–1932. 10.1017/S0033291720000720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Zielinski B., Prigge M., Nielsen J., Froehlich A., Abildskov T., Anderson J., et al. (2014). Longitudinal changes in cortical thickness in autism and typical development. Brain 137 1799–1812. 10.1093/brain/awu083 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES